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ABSTRACT 
Chemotherapy is a concept that strikes a chord inside many people, conjuring 
images of nausea, hair loss, and pain.  It is synonymous with cancer.  The impact of 
undergoing treatment for a life-threatening diagnosis like cancer can have both seen and 
unseen impacts on the person, their families, and their loved ones.  The effects can 
reverberate through a person’s life, affecting not only their health status, but also their 
relationships, careers, sense of self, worldview, and spirituality.  This study looks more 
closely at the experiences of women who have undergone chemotherapy for the treatment 
of breast cancer and considers the full range of experiences to better understand the 
effects it has on people’s lives.  Specifically, the purpose of this study is to lay the 
groundwork for the understanding of the impact of chemotherapy on breast cancer 
survivors.  Through 11 one-to-one interviews with women who have been treated with 
chemotherapy for breast cancer, this study will focus in-depth on what the experience of 
chemotherapy was like for these women and how it changed their lives. 
Major findings in this study include significant experiences of positive life 
changes in the realms of sense of self, relationships, and spirituality following 
chemotherapy.  This study can be broadened to include people undergoing many different 
invasive treatment procedures and affect how mental health professionals interact with 
and treat these populations. 
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CHAPTER I 
INTRODUCTION 
Chemotherapy is a concept that strikes a chord inside many people, conjuring 
images of nausea, hair loss, and pain. It is synonymous with cancer. The impact of 
undergoing treatment for a life-threatening diagnosis like cancer can have both seen and 
unseen impacts on the person, their families, and their loved ones. The effects can 
reverberate through a person’s life, affecting not only their health status, but also their 
relationships, careers, sense of self, worldview, and spirituality. When chemotherapy is 
chosen as a method of treatment, this impacts the person’s experience of the illness as it 
can cause a myriad of side effects that range from mild to life threatening, in and of 
themselves. These can lead to an array of responses that range from mild discomfort to 
symptoms of trauma (Stewart, Bielajew, Collins, Parkinson, and Tomiak, 2006, Mehnert 
and Koch, 2007, and Rabin, Leventhal, and Goodin, 2004). For many, chemotherapy 
changes the landscapes of their lives and is often regarded as being worse than the cancer 
(Docherty, Sandelowski, and Preisser, 2006). The DSM-IV-TR includes “being 
diagnosed with a life-threatening illness” as a traumatic event that can lead to the 
symptoms and diagnosis of Posttraumatic Stress Disorder (PTSD) (DSM-IV-TR, 2000, p. 
462). This study proposes to closely examine the specific stressors that can arise from 
chemotherapy as it is considered independently from cancer. Previous research has found 
that individuals undergoing chemotherapy experience changes in quality of life (e.g. 
Zebrack, Yi, Petersen, and Ganz, 2007, Hurria, A., Rosen, Hudis, Zuckerman, Panageas, 
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Lachs, Witmer, van Gorp, Fornier, D’Andrea, Moasser, Dang, Van Poznak, Hurria, and 
Holland, 2006, and Carver, Smith, Petronis, and Antoni, 2006), anticipatory nausea (e.g. 
Montgomery, Bovbjerg, 2003, and Montgomery,Bovbjerg, 2001), cognitive impairment 
(e.g. Falleti, Sanfilippo, Maruff, Weih, and Phillips, 2005, and Bender, Sereika, Berga, 
Vogel, Brufsky, Paraska, and Ryan, 2006), depression and anxiety (e.g. Reddick, Nanda, 
Campbell, Ryman, and Gaston-Johansson, 2005, and Deshields, Tibbs, Fan, and Taylor, 
2006), and fatigue (e.g. Jacobsen, Hann, Azzarello, Horton, Balducci, and Lyman, 1999, 
and Mills, Parker, Dimsdale, Sadler, and Ancoli-Israel, 2005). None of these studies, 
however, have looked at how these chemotherapy side effects have affected the realms of 
spirituality, sense of self, and worldview as this study does. 
What is it like when the treatment for the illness is what many consider to be the 
worst part? What about effects that aren’t considered to be traumatic, but still impact 
one’s life? This study looks more closely at the experiences of women who have 
undergone chemotherapy for the treatment of breast cancer and considers the full range 
of experiences to better understand the effects it has on people’s lives. Specifically, the 
purpose of this study is to lay the groundwork for the understanding of the impact of 
chemotherapy on breast cancer survivors. However, the implications of the findings of 
this study can be broadened and generalized to other cancers that have a chemotherapy 
protocol as well. These findings can be translated into ways to provide more emotional, 
physical, spiritual, and mental support for patients undergoing chemotherapy and allow 
for a better understanding of what happens when someone undergoes a life-threatening 
treatment. While the chemotherapy experience may not be explicitly traumatic, it is 
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possible that it is on a spectrum that includes its own set of psychologically distressing 
symptoms that need to be addressed in the field of mental health.      
Through one-to-one interviews with women who have been treated for breast 
cancer, this study will focus in-depth on what the experience of chemotherapy was like 
for these women and how it changed their lives, for good, bad, or not at all. This kind of 
information can lead to a better understanding of what is needed by cancer patients 
before, during, and after chemotherapy. Are their mental health needs being met? Are 
their relationships being strained? Has it raised questions regarding their faith? Do they 
regret the decision? All of these are important factors to consider when treating a person 
as a whole and should not be overlooked by the medical and mental health communities. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4 
 
 
CHAPTER II 
LITERATURE REVIEW 
A 2006 case study examined the reactions of a teenage girl, Abby, undergoing 
chemotherapy for the treatment of Hodgkin’s Lymphoma (Docherty, Sandelowski, and 
Preisser, 2006). What the authors observed was the young woman “fighting the 
treatment, as opposed to fighting the cancer. (Her) response to her symptoms frightened 
her, and she felt that she might not be up to the challenge” (Docherty et al., 2006, p.305).  
Abby wrote in her journal “(w)ell, it’s a feeling that I had for awhile with this. It didn’t 
seem right. It just didn’t make any sense to me that for my body to get better, I have to 
completely break it down and get sick and just, and just so I can get better. It just didn’t 
seem right” (Docherty et al., 2006, p.304). In a 1997 case study, Flemons followed a 
woman, Judith Shulimson, through her treatment for breast cancer and included segments 
from her journal in his case study. She wrote that “(t)he cure is worse than the disease, 
especially since the disease hasn’t really caused me any problems so far; it’s the 
treatment that has made me so sick….The first chance I get to think about continuing 
with chemotherapy I start thinking of running away….Chemotherapy: metaphors of 
aggression, destruction, violence, warfare” (Flemons and Shulimson, 1997, p.182). The 
irony of the cure being worse than the disease is hardly a novel idea and is certainly not 
limited to chemotherapy. Around 100 BC, Greek philosopher Publilius Syrus stated that 
“(t)here are some remedies worse than the disease.” This idea seems to be especially 
highlighted in the use of chemotherapy to treat cancer. The side effects can result in 
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myriad changes that people may experience for the rest of their lives, or at least long after 
treatment for their cancer has ended. For women with breast cancer this can be especially 
poignant as they are already wrestling with a sickness that has struck in a place that, for 
many, is an important part of their identity and sexuality. When chemotherapy ends it 
does not necessarily denote the end of its impact. 
Co-Morbids 
Multiple studies have found that chemotherapy has been associated with high co-
morbidities of both a physical and psychological nature (Maguire, Faulkner, Booth, 
Elliot, and Hillier, 1996, Wilkinson, 1991, and Watson, Meyer, Thomson, and Osofsky, 
1998). The psychological co-morbidities looked at in this study are Posttraumatic Stress 
Disorder, Anxiety Disorders, and Depression, as well as general feelings of lowered 
emotional and affective functioning caused by side effects. 
Posttraumatic stress disorder (PTSD) 
The DSM-IV-TR explains PTSD, in part, as the development of certain 
“symptoms following exposure to an extreme traumatic stressor involving direct personal 
experience of an event that involves actual or threatened death or serious injury, or a 
threat to one’s physical integrity” (American Psychiatric Association (APA), 2000, 
p.463). It goes on to include “being diagnosed with a life-threatening illness” (APA, 
2000, p.464) as one of these traumatic stressors. With these criteria in mind, 
chemotherapy certainly seems to fit this bill, as well as the diagnosis of cancer itself. 
With its dramatic side effects and reputation for being worse than the cancer, 
chemotherapy appears to fit the bill of being a “traumatic stressor” (APA, 2000, p.463).   
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Much of the current research regarding PTSD symptoms and breast cancer is 
focused on the diagnosis (Tjemsland, Soreide, & Malt, 1996) or the overall experience 
itself (Rabin, Leventhal, & Goodin, 2004, Mehnert & Koch, 2007, and Amir & Ramati, 
2002). Much of the findings from these studies highlight the fact that “(t)here is evidence 
that a number of patients develop cancer- or treatment-related PTSD” (Mehnert & Koch, 
2007, p.186). However, the findings also supported the strong link between patients’ 
understandings about the cancer and the treatment and subsequent symptoms of PTSD.  
According to Rabin et al. (2004), the emotional reactions of most patients to their illness 
are due in large part to their beliefs about the disease, not medical information. This 
underscores the importance of a patient’s state of mind and beliefs while undergoing 
chemotherapy in determining how the treatment will effect them post-treatment. Amir 
and Ramati (2002) found a correlation between women receiving chemotherapy with a 
low-disease stage and a higher risk for developing PTSD-like symptoms. A possible 
theory behind their finding is “that the coping style of suppression in a supposedly 
healthy woman (low disease stage), combined with difficult chemotherapy, creates the 
most fertile ground for the development of PTSD symptoms” (Amir & Ramati, 2002, 
p.204) thus underscoring the profound impact of chemotherapy and the associated beliefs 
a patient may have with it in determining its long-term effects in survivors. 
Taieb, Moro, Baubet, Revah-Levy, and Flament (2003) looked at PTSD 
symptoms in young survivors of childhood cancer and their parents. They found that “it 
is both the diagnosis of cancer (an acute event of life threat) and its treatment (a long-
lasting or repetitive threat to both life and physical integrity), which are experienced as 
the traumatic events by children and their parents” (Taieb et al., 2003, p.262).   
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Tjemsland et al. (1996) conducted a study in which they focused solely on the 
experience of being diagnosed with breast cancer and the time leading up to initial 
surgery. They found that “nearly half of the patients reported a high level of intrusive 
thoughts during the days immediately following diagnosis” (Tjemsland et al., 1996, p.6).  
Could some of these intrusive thoughts be related to anticipation anxiety for what the 
patients may assume to be a treatment protocol that may include chemotherapy? 
Certainly it’s hard to separate the concept of cancer from its most high-profile treatment. 
Psychological distress including depression, anxiety, and cognitive functioning  
Several studies have cited psychological distress (including depression, anxiety, 
emotional expression, and neuropsychological effects) as a phenomenon commonly 
associated with breast cancer and its treatment. Pieterse, van Dooren, Seynaeve, Bartels, 
Rijnsburger, de Koning, Klijn, van Elderen, Tibben, & Duivenvoorden (2007) related 
coping styles with psychological distress measurements. They found that “(a)pproach 
coping (trying to do something about the stressor) for instance, was found to be more 
beneficial than avoidant coping (trying to avoid the stressor)” (Pieterse et al., 2007, 
p.851). Moreover, Pieterse et al. found that when a patient either sought out, or had in 
place, strong social support this could decrease levels of psychological distress and was 
in line with the results associated with active coping styles. A study by Manne, 
Glassman, and Du Hamel (2000) found that a decline in physical abilities in women with 
cancer predicted maladaptive coping strategies more often in those with lower-stage 
cancer than those with a higher stage. This would seem to imply that the psychological 
distress experienced by healthier seeming women is greater and more drastic than that of 
women who may be sicker. Reddick, Nanda, Campbell, Ryman, & Gaston-Johansson 
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(2005) had findings that were consistent with this hypothesis and also found that “coping 
plays a significant role in the process of psychosocial adaptation to breast cancer” 
(Reddick et al., 2005, p.151). Again, this underscores the connection between the impact 
of cancer and chemotherapy and women’s self-views. It also speaks to the idea that 
women with better coping strategies may find that previously held personal beliefs are 
less affected by treatment. Shapiro, Boggs, Rodrigue, Urry, Algina, Hellman, and Ewen 
(1996) studied differences in various coping styles and found that side effects were less 
profound in women with a confrontive coping style, that is, women who sought out 
information and were willing to talk about cancer both in and out of the treatment setting, 
as well as women who reported higher levels of optimism. “(C)oping patterns were 
significant predictors of physical, psychological, and total side effects in women with 
stage II breast cancer receiving adjuvant chemotherapy” (Shapiro et al., 1996, p.152). As 
to optimism having an effect on lone-term psychological well-being, Tartaro, Roberts, 
Nosarti, Crayford, Luecken, and David (2005) wanted to know what consequences and 
outcomes, if any, women saw who were able to find some benefit in their course of 
illness and treatment. What they found in this study was that prior to diagnosis, while 
seeking treatment for their symptoms, the women who reported higher levels of distress 
were the same women who were able to find benefit in their cancer and treatment 
experience, thus plummeting their distress scores during their course of treatment. 
However, two-and-a-half years following the end of treatment, women who had found 
benefit and women who had not, were equal in levels of distress in quality of life (QOL) 
and adjustment. One notable difference was that spiritual well-being was reported as 
higher by the women who felt they had found some meaning in their cancer than those 
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who did not (Tartaro et al., 2005). Whether this is caused by the cancer diagnosis alone, 
or is on part due to the course of chemotherapy, is what this study aims to look at.   
Lam, Chan, Ka, and Fielding (2007) looked at treatment decisions made post-
surgery by Chinese women and found that those who had difficulties deciding on a 
course of treatment, and had experienced distress during the early post-operative period, 
“were at greater risk of persistent psychological morbidity” (Lam et al., 2007, p.910).  
“(P)sychological morbidity is not just a transient reaction to diagnosis and treatment of 
breast cancer, with 49% reporting psychological morbidity lasting at least 8-months” 
(Lam et al., 2007, p.910). This statistic, when compared with the rate of psychological 
morbidity in Caucasian women, was significantly higher. Interestingly enough, the 
authors noted that this discrepancy may have more to do with the younger average age of 
their participants, 51.2, than with their ethnicity, as they were being compared to women 
in western studies with the average age of 59.4. This correlates with studies about 
younger women having more adverse reactions to chemotherapy, as discussed in a later 
section. 
While depression is not a statistically likely response to breast cancer treatment, 
when it is a factor it can have over-arching consequences that can lower perceived QOL 
(Deshields, Tibbs, Fan, & Taylor, 2006). “Depressive symptoms can affect interpersonal 
relationships, occupational performance, perceptions of health, and physical symptoms” 
(Deshields et al., 2006, p.404). According to other studies, a third of people with cancer 
will develop a depressive illness and/or an anxiety disorder (Derogatis, Morrow, Fetting, 
Penman, Piasetsky, and Schmale, 1983, and Parle, Jones, and Maguire, 1996). As cited in 
Chan, Ho, and Chan (2007), “Zebrack concluded that ‘quality of life outcomes partially 
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may be a function of the cognitive frame or meaning that survivors attribute to their 
experience’” (Chan et al., 1999, p.847). Certainly, if a person is suffering from depressive 
symptoms this framework would be significantly affected and thus their feelings 
regarding identity and self-view, among other things. In a study comparing depressive 
symptoms immediately following treatment and again 2 years after diagnosis, Sharpley 
and Christie (2007) found that women’s initial self-reports were higher than those 
subsequent. “(T)hey placed less weight upon the somatic symptoms as time went by and 
instead emphasized more their lack of ability to cope with demands of having cancer, 
their mental confusion and their feelings of hopelessness and loss of previously valued 
activities” (Sharpley & Christie, 2007, pps.759-760). This finding begs the question 
about how many of these symptoms were due to anxiety and fear proceeding the start of 
chemotherapy and then morphed into concerns about quality of life and loss of cognitive 
functioning following the end of treatment.   
A meta-analysis of studies conducted by Stewart, Bielajew, Collins, Parkinson, 
and Tomiak (2006) found significant results linking cognitive decline with adjuvant 
chemotherapy for breast cancer. “It has been suggested that these changes are a 
consequence of chemotherapy-related neurotoxicity” (Stewart et al., 2006, p.77). In this 
study a decline in visual memory, attention, visuospatial functioning, learning, speed of 
processing, and verbal learning were linked with women who had undergone 
chemotherapy for the treatment of their breast cancer (Stewart et al.). A meta-analysis of 
six studies on the subject found that “chemotherapy may give rise to some generalized 
cognitive impairment” (Falleti, Sanfilippo, Maruff, Weih, & Phillips, 2005, p.66). Yet 
another study also found declines in verbal memory but not visual memory, however, this 
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study also found that “perceptions of cognitive impairments were evident immediately 
following the conclusion of chemotherapy. Thus, the subjective reports of cognitive 
impairment preceded declines detected by the objective measures” (Bender, Sereika, 
Berga, Vogel, Brufsky, Paraska, & Ryan, 2006, p.428). A perceived cognitive decline 
that occurs before an objectively measurable one could be argued to be due, at least in 
part, to previously held beliefs about chemotherapy and its side effects as understood in 
our culture. Such beliefs could weigh heavily in the impact such a treatment has. One 
could speculate that any deterioration in such significant areas of cognitive functioning 
would most assuredly have some impact on a patient’s sense of identity. 
A study by Farrell, Heaven, Beaver, and Maguire (2005) looked at women 
undergoing in-patient chemotherapy and how responsive their caregivers were to their 
needs, including psychological needs. They found that nurses in the ward identified about 
20% of the actual concerns of patients and “were least likely to identify concerns about 
the future and psychological concerns” (Farrell et al., 2005, p.74). This is an interesting 
phenomenon in that it may have a profound effect on a woman’s experience of 
chemotherapy if she feels that her caregivers are not in-tune with many of her needs. If 
psychological needs go unaddressed in treatment, such as feelings of sadness or anxiety, 
then it can’t be assumed that they will go away once treatment is concluded and not 
remain as an ongoing concern. 
A study by Alder and Bitzer (2003) looked at which stages of treatment women 
experienced positively and which were more negative. The stages were broken down into 
diagnosis, in-patient treatment, chemotherapy, radiotherapy, and after-care and the survey 
was given to women who were within 5 years of being diagnosed with breast cancer. 
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What they found was that “the first diagnostic phase and the phase of chemotherapy 
represented the most strainful” (Alder & Bitzer, 2003, p.93). They found that the 
significance of patients having a negative experience during chemo- or radiotherapy had 
higher depression and anxiety scores at the time of the survey. Women who reported 
having had an overall negative experience with the medical system also showed higher 
anxiety and depression scores (Alder & Bitzer, 2003). The implications of this study 
suggest that a possibly mitigating influence during chemotherapy could be the 
interactions with healthcare workers. It is possible that these types of encounters could 
help ease feelings of anxiety and depression brought on by the side effects and 
psychological impact of undergoing chemotherapy, thus making its impact less profound.   
Last to note, “(l)iving through the cancer of a close family member…could 
contribute to a learning history that vividly equates cancer with extremely noxious 
outcomes. This could leave women in a heightened state of fear and anxiety over the 
consequences of personally experiencing cancer” (Badger, Segrin, Meek, Lopez, & 
Bonham, 2005, p.96). Is it the cancer itself, the fears related to treatment, or a 
combination of both that create these “noxious outcomes”? 
Nausea 
Perhaps one of the most common side effects traditionally associated with 
chemotherapy is nausea. Anticipatory nausea has been studied (Montgomery & Bovbjerg, 
1996) to determine factors associated with expectations of nausea, time nausea begins in 
relation to infusion, and change in pattern as treatment progresses. Results indicate that as 
patients progress in their treatment their anticipatory nausea becomes based on real-life 
experience of it and not just previously held beliefs (Montgomery & Bovbjerg, 2001). A 
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third study by Montgomery and Bovbjerg (2003) showed a correlation between 
emotional distress and anticipatory nausea before the first infusion and with no prior 
history of receiving chemotherapy. The fact that anticipatory nausea can happen even 
before the first infusion of chemotherapy goes to show how deeply ingrained in our 
cultural awareness this side effect is and raises questions about how this affects a 
patient’s overall experience of the treatment and their own role within it. 
It’s not only anticipatory nausea that is a side effect of chemotherapy, but delayed 
nausea as well. “(D)elayed nausea and vomiting (i.e. nausea and vomiting occurring more 
than 24 h post-chemotherapy) was a considerable problem. Delayed nausea was present 
for 5 days and vomiting for 3 days post-chemotherapy” (Molassiotis, 2000, p.233). Such 
an intense side effect is not without its consequences, especially when considered in the 
context of receiving multiple infusions over the course of treatment. 
Fatigue 
Similar to nausea, fatigue is one of the most common side effects experienced by 
people undergoing chemotherapy. According to Servaes, Verhagen, and Bleijenberg 
(2002) it is, in fact, the most common side effect. Bovbjerg, Montgomery, and Raptis 
(2005) considered whether or not fatigue could be considered to be a conditioned 
response to chemotherapy. Their results indicate that there is a significant relationship 
between the two, even going so far as to speculate that the results may last well past the 
end of treatment. As Cameron, Cella, Herndon, Kornblith, Zuckerman, Henderson, 
Weiss, Cooper, Silver, Leone, Canellos, Peterson, and Holland (2001) found, it’s not 
uncommon for patients to re-experience nausea when returning to the clinic long after 
their treatment has ended. Another notable effect of this possibly conditioned response, 
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similar to the data on nausea, is that of anticipatory fatigue (Bovbjerg et al., 2005). As 
with anticipatory nausea, the researchers in this study noted a certain number of subjects 
that appeared to suffer from fatigue before even their first infusion of chemotherapy. 
Considering the possible psychological impact of a conditioned response of either nausea 
or fatigue, or both, it is significant to note that sometimes the symptom occurs before the 
stimulus has even been introduced. Can it be that the possible side effects of 
chemotherapy are so commonly known that they can actually happen when 
chemotherapy is just anticipated? This would seem to indicate a rather strong reaction to 
the treatment, outside of its physical effects. A third common side effect, stress, has also 
been studied as an anticipatory phenomenon (Lekander, 2001). “The present pattern of 
data indicates that immune variables change as a function of anticipation when cancer 
patients report to the treatment-associated milieu” (Lekander, 2001, p.36). Lekander goes 
on to speculate that this reaction can be due to either the conditioned response, or, in the 
case of patients who have yet to undergo their first infusion, “higher mental functions” 
(Lekander, 2001, p.37). If the stimulus is coming from the patient’s imagination, than it is 
a powerful force, indeed.   
This finding proves to be even more significant in light of the research by Mills, 
Parker, Dimsdale, Sadler, and Ancoli-Israel (2005) who found that “the increased ratings 
of depressed mood in response to chemotherapy were best predicted by pre-treatment 
ratings of depressed mood and by fatigue in response to chemotherapy” (Mills et al., 
2005, p.92). Anticipatory responses have the potential to have a great impact on post-
treatment reactions. When fatigue is elevated, women tended to report that it “interfered 
to a greater extent with their general activity, ability to bathe and dress, normal work 
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activity, ability to concentrate, relations with others, enjoyment of life, and mood” 
(Jacobsen, Hann, Azzarello, Horton, Balducci, and Lyman, 1999, p.239). Alterations to 
one’s lifestyle of this magnitude, from a combination of real and perceived possible side 
effects, have the potential to drastically impact many beliefs held by the person 
experiencing them. Self-view, identity, sexual identity, and spirituality are all likely to be 
considered during such a painful period. 
Quality of Life/Identity 
Quality of life 
Quality of life (QOL) includes such realms as physical and emotional functioning 
and health, social functioning, vitality, sleep quality (Stein, Jacobsen, Hann, Greenberg, 
and Lyman, 2000), body image, future perspective, and sexual functioning/enjoyment 
(Janz, Mujahid, Lantz, Fagerlin, Salem, Morrow, Deapen, and Katz, 2005) among other 
things. Irwin, Arnold, Whelan, Reyno, and Cranton (1999) found in their research on 
subjects who got to choose between a more aggressive and shorter course of 
chemotherapy versus a longer course with fewer side effects, that “quality of life is 
subjective and can only be defined by the individual based upon what he/she believes 
matters most” (Irwin et al., 1999, p.290). There have been many studies on the realm of 
how disease affects people’s perceived quality of life, particularly in breast cancer 
research. This research relates to the current study in that the specific role that 
chemotherapy plays in that process is being examined. It is interesting to note that many 
of the following studies show an initial decrease in QOL during treatment, and a return to 
previous levels in the months following treatment completion. 
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In a study by Buick, Petrie, Booth, Probert, Benjamin, and Harvey (2000), the 
researchers sought to compare the change in affect and function between women referred 
for chemotherapy and those referred for radiotherapy for breast cancer. What they found 
is that “(r)adiotherapy and chemotherapy produce low to moderate psychological distress 
and functional impairment” (Buick et al., 2000, p.54). However, when the two groups 
were directly impaired, they found that the women referred for chemotherapy 
experienced more functional impairment and negative affect than did those referred for 
radiotherapy, as well as more disturbance to their sleep and managing within the home. 
Overall, they found that “(r)eferral for chemotherapy as opposed to radiotherapy appears 
to produce an 8% to 25% increase in impairment of everyday activities” (Buick et al., 
2000, p.55). In other words, before treatment has even begun, many women experience a 
negative daily impact in their lives for just having been referred for chemotherapy. The 
final factor these researchers considered was the impact of the side effects of 
chemotherapy on subjects’ affect and functioning levels. Hair loss, bladder infections, 
and nausea “are not conducive to maintaining one’s social, vocational, and domestic 
responsibilities and interpersonal relationships. Psychosocial disruption associated with 
chemotherapy may affect patients’ perception of their ability to meet role demands and 
personal expectations” (Buick et al., 2000, p.56). This shift in perception has the potential 
to greatly affect a person’s sense of mastery and autonomy, and thus their overall self-
image. The ways in which a woman copes with these stressors could be integral for how 
she feels about herself when treatment is completed. 
One side effect of chemotherapy in particular, hot flashes, has been estimated to 
occur in about 40% of women in chemotherapy treatment for breast cancer (Stein et al., 
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2000). Stein et al. also found that 58% of those women found them to be somewhat to 
very distressing. “(W)omen with hot flashes experienced poorer sleep quality, higher 
levels of fatigue, and poorer physical health compared to women without hot flashes” 
(Stein et al., 2000, p.443). This same study also found a significant relationship between 
hot flashes and poorer quality of life. As an exclusive symptom of chemotherapy, hot 
flashes are unique in that they can provide reasonable evidence as to the potential impact 
that this treatment alone can have on women. 
The Janz et al. (2005) study found evidence to suggest “that adjuvant 
chemotherapy had a greater impact on QOL than which surgical procedure was 
performed. While the largest QOL differences were found in areas of body image and 
future perspective, meaningful differences were also observed in social well-being and 
fatigue” (Janz et al., 2005, p.1477). Also interesting to note, this same study found that 
these QOL impacts had more of a detrimental effect of younger versus older women. It 
can be speculated that this could, in part, be due to the side effects producing more of a 
disturbance in the lives of younger women who may be working more, caring for a young 
family, and possibly never having dealt with any prior major health issues. Janz et al 
noted in this study that there did not appear to be any discrepancies across race when 
testing for QOL changes, but did note that “chemotherapy had a disproportionately 
greater impact on women with lower levels of education…(i)n this study women who 
reported having less than a high school diploma were also more likely to be minority, of 
lower income, and unemployed” (Janz et al., 2005, p.1477). This finding can have 
implications on the types of support networks these women have and, similar to the 
results found for young women, have more of a profound impact on their day-to-day 
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functioning. Daily functioning includes not only being financially secure enough to miss 
work, but also the toll that fatigue and all the other symptoms can take on women who 
may have to do more active and hands-on jobs. Carver, Smith, Petronis, and Antoni 
(2006) had slightly different findings in their study on QOL. They found that “Hispanic 
women reported more frequent negative feelings, more social avoidance, more distress 
about their family’s future, and more distress about the possibility of recurrence than did 
other women” (Carver et al., 2006, p.756). Spencer, Lehman, Wynings, Arena, Carver, 
Antoni, Derhagopian, Ironson, and Love (1999) said that “(a)lthough differences 
emerged between age and ethnic groups in profiles of concerns felt and distress levels 
experienced, associations among the variables did not vary significantly by subgroup” 
(Spencer et al., 1999, p.167). Spencer et al. (1999) also found no correlation between 
these differences and socioeconomic status and went on to infer that the reason Hispanic 
women reported higher levels of distress may be due to cultural factors, such as 
acknowledgement of feelings being appropriate for them culturally. In contrast, Spencer 
et al. found that African American women reported much less concern regarding pain and 
sexuality. Again, the researchers speculated as to whether or not this was due to culturally 
maintaining a strong image. 
As previously mentioned, several studies have found that in the long term, 
chemotherapy does not result in significant declines in QOL. While Schou, Ekeberg, 
Sandvik, Hjermstad, and Ruland (2005) found this to be the case in their study, which 
looked at health-related QOL predictors, they also found that QOL did decline 
immediately following cessation of treatment for some populations. “(P)oorer social 
functioning was associated with chemotherapy at three months and younger age at three- 
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and 12-months” (Schou et al., 2005, p.1820). Contrary to evidence from previously cited 
studies, Schou et al. found no correlation between chemotherapy and cognitive 
functioning. Winer, Lindley, Hardee, Sawyer, Brunatti, Borstelmann, and Peters (1999) 
in their study state that “QOL was significantly better in patients who were disease-free at 
the time of the interview compared to patients with evidence of recurring disease” (Winer 
et al., 1999, pps.171-172). Said interview was conducted 12 months post-treatment for all 
subjects. These results indicate with what relief people may once again to experience 
their lives once their course of treatment has ceased, and with what dread those who have 
to go through it again still feel. While the current study suggests that chemotherapy has 
profound effects on women who undergo it, particularly with identity and QOL, the idea 
that life can take on a new and positive meaning and level of enjoyment once treatment is 
over is in line with this hypothesis. “An improvement in overall quality of life and 
emotional well-being was demonstrated from before to 6 months after chemotherapy. 
This is likely related to completion of chemotherapy treatment, resolution of 
chemotherapy-related side effects, and return to normal living” (Hurria, Rosen, Hudis, 
Zuckerman, Panageas, Lachs, Witmer, van Gorp, Fornier, D’Andrea, Moasser, Dang, 
Van Poznak, Hurria, and Holland, 2006, p.929). Having once experienced such a 
profound regiment of treatment it isn’t unusual to see many people seek to find 
enjoyment in life, even if it is under a globally new way of thinking. 
Finally, Zebrack, Yi, Petersen, and Ganz (2007) looked at how several different 
factors prior to treatment affected long-term QOL. In regard to age, they found that 
“older individuals may not be faced with concurrent demands of work and childrearing, 
which may complicate adaptation in younger individuals and lead to more distress and 
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poorer QOL” (Zebrack et al., 2007, unknown page #). Other demographic factors also 
influenced QOL, including income level and comorbidities (Zebrack et al.). 
Sex 
Sexual functioning and enjoyment is an area of QOL that bears consideration as it 
is also affected by chemotherapy. Winer et al. (1999) found that a “large proportion of 
patients reported decreased sexual interest and activity, as well as pain or difficulty with 
intercourse, at the time of the interview” (Winer et al., 1999, p.172). They also 
acknowledge that “(f)urther research is needed to determine if changes in sexual function 
are related to hormonal changes that occur as a consequence of high dose chemotherapy, 
are representative of physiological sequelae of serious illness, or are due to some other 
combination of factors” (Winer et al., 1999, p.172). In a 2006 study by Archibald, 
Lemieux, Byers, Tamlyn, and Worth, the researchers looked specifically at the symptoms 
of chemically-induced menopause (prompted by chemotherapy) and women’s sexual 
functioning. “During interviews, 21 participants (70%) described experiencing one or 
more negative changes in their sexual functioning associated with CIM (chemically-
induced menopause)” (Archibald et al., 2006). This decrease in sexual functioning “was a 
negative and meaningful experience for the majority of the breast cancer survivors in this 
study. For many of the women, negative changes in sexual functioning introduced a sense 
of guilt, frustration or anger, or led to worries about their future well-being or their 
relationship with their partner. Often changes in sexual functioning were closely tied to 
how breast cancer survivors viewed themselves as women or sexual beings” (Archibald 
et al., 2006, p.100). Sexual functioning and identity are considered to be integral parts of 
QOL for most people. The impact of chemotherapy on this realm of identity for many 
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women is profound and can lead to new and different thinking about sexual identity, 
functioning, and desire for a long time following the end of active treatment. Taylor, 
Lamdan, Siegel, Shelby, Hrywna, and Moran-Klimi (2002) did a more specific study and 
looked at how breast cancer and its treatments affected African American women and 
their sense of sexual attractiveness. They “conceptualized sexual attractiveness as a 
construct that is related to body image and thus expected to find results similar to earlier 
studies of body image that were conducted with largely Caucasian samples” (Taylor et 
al., 2002, p.513). The results that they found were that “addressing concerns about body 
image and sexual attractiveness received low priority” (Taylor et al., 2002, p.514) for 
African American women when discussed in a group therapy setting. This could be due 
to either the nature of the issue, the nature of the setting in which it was being discussed, 
or some combination of the two, for the women. Regardless, the researchers “found that 
it was the women who had chemotherapy in combination with a lumpectomy who 
reported the greatest difficulties regarding feelings of sexual attractiveness” (Taylor et al., 
2002, p.513). They attributed this, in part, to the side effects of chemotherapy, including 
loss of hair, discoloration of the skin, and weight gain. Whatever the severity, area, or 
personal impact chemotherapy has on sexual functioning and attractiveness, it is a factor 
in identity and this makes it worth further consideration. 
Treatment Decisions 
The potential for being affected by chemotherapy doesn’t just begin when a 
woman is diagnosed with breast cancer. Rather, its implications and side effects are in 
mind for many women during cancer screenings, such as mammograms. One study found 
that women with locally advanced breast cancer had delayed screening due in part to the 
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fear of side effects of treatment (Mohamed, Williams, Tamburrino, Wryobeck, and 
Carter, 2005). These women “denied having yearly mammograms or performing monthly 
breast self-exams” (Mohamed et al., 2005, p.403). Within this same study, these women, 
when compared with the control group, showed no difference between education, 
employment, marital status, or awareness of preventative health guidelines. Additionally, 
both groups reported the same percentages of those with health insurance. A possible 
conclusion from this could be that there is a segment of women in the population who 
wind up with locally advanced breast cancer that is due in part to their fear of 
chemotherapy and its side effects. 
In a very different study from the previous one, Muir, Meiser, Tucker, Andrews, 
Tucker, K., and Friedlander (2004) looked at women in a high-risk group for breast 
cancer and their willingness to participate in chemoprevention. Chemoprevention is used 
as a means of reducing the risk of breast cancer in high-risk women by using drugs such 
as tamoxifen, an estrogen suppressor (Muir et al., 2004). The study found that around half 
of the women interviewed would be willing to participate in clinical trials of 
chemoprevention with the other half citing that they would not be willing to participate 
for “fear of side effects” (Muir et al., 2004, p.43). While participating in such a measure 
to maybe prevent the possible development of breast cancer may seem extreme, some 
women may view it as a way to avoid later, and possibly worse, side effects from actual 
chemotherapy. For these women it is a price they are willing to pay, which is a factor that 
cannot be ignored. 
The end of treatment is a time during which women can experience very 
ambivalent feelings about chemotherapy. Despite its numerous side effects, many women 
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perceive some courses of chemotherapy with high rates of side effects, such as 
adriamycin, as being more effective and aggressive than other courses of chemotherapy 
with fewer side effects (Irwin et al., 1999). With this in mind, it should come as no 
surprise that for many women the end of chemotherapy, and cancer treatment as a whole, 
represents a time of crisis and worry (Arnold, 1999). Fear of recurrence may emerge as a 
large concern for many women, particularly those who acknowledge that while they were 
in chemotherapy they felt like they were actively fighting their cancer. A subject in the 
study by Arnold (1999) said “I guess having medical people taking charge of your life 
and body makes me feel more secure and being on treatment made me feel that at least I 
had something in my body fighting to kill the cancer….To be honest, it scares the hell out 
of me sometimes not having that ‘safety net’ of treatment” (Arnold, 1999, p.27). As 
Arnold states in her summation of this statement: “(t)reatment may be an anxiety-
provoking unpleasant experience, but it is a proactive process that gives many women the 
comfort that they are ‘doing something’ instead of waiting to see what the future holds” 
(Arnold, 1999, p.27). The expectations of others also weigh heavily during this time, as 
one subject reported, “(p)eople on the outside assume that once you are ‘cured’ and ready 
to return to whatever you did before with the full vim and vigor of the ‘before’ cancer 
you- as if nothing happened” (Arnold, 1999, p.29). What “happened” for these women 
was that they underwent intensive chemotherapy and many of them will be dealing with 
the after effects and consequences of this for an undetermined amount of time. They 
grapple with both the fear of the unknown future, and integrating their treatment 
experiences into what they know about themselves and the world. “Before my last 
chemo, I loved being alone in the house when my husband and daughter were out of 
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town, but now I hate being alone and fear choking to death while eating alone, or getting 
very ill in the middle of the night when I’m alone” (Arnold, 1999, p.32). Fear of the 
future, both recurrence and the unknown, is a valid fear for many of these women. 
Supporting these findings, Chantler, Podbilewicz-Schuller, and Mortimer (2005) found 
that “participants in our focus groups reported exaggerated fear of cancer recurrence and 
death from breast cancer. Fear began with the diagnosis, abated while on active therapy, 
and worsened as active treatment was completed and contact with health professional(s) 
decreased” (Chantler et al., 2005, p.75). There is a balance needed between 
understanding the benefits of chemotherapy and truly being in touch with its potentially 
life-altering consequences. 
Partners/Caretakers 
The role of caretakers and partners is an important one during chemotherapy. 
They spend the most time with the women and often witness many of the chemotherapy’s 
side effects firsthand. A study by Segrin, Badger, Dorros, Meek, and Lopez (2007) found 
“emotional contagion on anxiety, emanating from partners to the women with breast 
cancer, but not vice versa” (Segrin et al., 2007, pps.639-640). This indicates yet another 
realm in which women may have to face symptoms from their chemotherapy: the distress 
that it is causing their partner to watch them undergo treatment. Additionally, this study 
found that women’s anxiety and depression were closely associated with their partner’s 
levels in these realms. “(P)artners’ anxiety was positively associated with depression, 
symptom distress, mental fatigue, and physical fatigue, and negatively associated with 
symptom management among women with breast cancer” (Segrin at al., 2007, p.640). 
Thus, it would seem that a partner’s management of his/her anxiety and depression is 
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critical to the woman’s ability to cope with her own psychological side effects. 
Similarities in feelings experienced by partners to women also was found in the study by 
Mohamed et al. (2005). This was a study that examined treatment decisions made by 
women with locally advanced breast cancer. They found “significantly greater depression 
and active religious surrender than the control partners” (Mohamed et al., 2005, p.403) 
which correlated with the “(g)reater active religious surrender” (Mohamed et al., 2005, 
p.403) seen in the women with locally advanced breast cancer. In the study by Chantler et 
al. (2005), the authors found that women with male partners tended to report that the 
“men were less ‘emotionally available’ than women” (Chantler et al., 2005, p.76). 
Overall, “(m)en were effective in providing verbal statements of encouragement and 
optimism. Although this support was viewed as being extremely helpful at the point of 
diagnosis, women became frustrated when they requested support by discussing less 
optimistic aspects of their disease” (Chantler et al., 2005, p.76). It may be that when a 
husband is vicariously experiencing the effects of his wife’s chemotherapy he is less 
likely to be able to provide the kind of psychological support that she may feel she needs.  
Harrison, Maguire, and Pitceathly (1995) found that it can be especially difficult for men 
watching their wives undergo treatment as she is usually the person to whom they are 
closest emotionally, thus making it harder for them to burden her with their own feelings. 
This could be true for all caretakers in that they may find it difficult to manage their own 
emotional reactions to seeing their loved one go through chemotherapy and subsequently 
have a hard time providing the kind of support the woman needs. There are many ways in 
which this could affect the woman, but this has yet to be studied. It has been shown that 
it’s common for couples to draw on their mutual bond “to develop their confidence in 
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their ability to deal with the issues associated with the disease (dealing with the unknown, 
the threat of loss, the uncertainties and changes, and organization of the support network) 
and to transform this experience of suffering into a meaningful and constructive life 
experience personally and conjugally” (Picard, Dumont, Gagnon, & Lessard, 2005, 
p.132). However, this same study also confirmed that in order for these more positive 
outcomes to happen, it was important that “love existed before the disease” (Picard et al., 
2005, p.132). Ideally this would be the case in all relationships but sadly, is not. Many 
women undergo chemotherapy and other treatments without the emotional, 
psychological, mental, and physical support of a loving partner. “(F)eelings of fighting 
the battle of cancer alone may be frightening and contribute to a diminished sense of 
well-being” (Arnold, 1999, p.31). Sense of self and worldview may be just two schemas 
that could be affected by such an experience. 
The end of treatment marks another time of transition for women and their 
support networks. In Arnold’s study one respondent remarked that “(o)nce treatment is 
over, you have no one to talk to” (Arnold, 1999, p.30). This feeling may result, at least in 
part, from the woman’s own internal struggle to incorporate new thoughts and beliefs into 
her existing schemas. She may feel alien in the world in which she previously operated. 
Conclusion 
There is still a lot to be learned about the effects of chemotherapy and how they 
affect survivors. Once faced with a treatment regimen that many consider to be worse 
than the disease, it doesn't seem unexpected that many people experience a shift in some 
of their previously held beliefs and views. Sense of self, worldview, sexuality, and 
religion are a few examples of realms that may be influenced. As the literature has 
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shown, chemotherapy has many side effects, not all of them physical. This study seeks to 
find out more about the consequences, expected and unexpected, positive and negative, 
that women experience as a result of their having been through this arduous treatment.   
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CHAPTER III 
METHODOLOGY 
This study is an exploratory look into the types of quality of life changes women 
may experience after receiving chemotherapy for the treatment of breast cancer. It is 
based on the premise that facing such a serious and potentially dangerous treatment may 
have profound and lasting effects on sense of self, spirituality, relationships, and 
worldview. The study was designed using content analysis to code for themes that 
emerge across participants. Through an hour long, one-on-one interview, participants 
were asked to reflect back on the nature of their chemotherapy experience. The interview 
questions centered on the physical, emotional, mental, and spiritual areas of identity. The 
open-ended structure of the questions was designed to prompt further exploration of the 
topics through narration, and as such, were specific to this study. “Available instruments 
are not generally used because this would defeat the basic purpose of the research: to 
learn inductively about a phenomenon that was previously unknown or poorly 
understood” (Anastas, 1999, p.354). The goal was to invite participants to evaluate the 
ways in which they perceived themselves to be different than they were prior to breast 
cancer, and process what changes, if any, were due to the chemotherapy experience. The 
questions were developed and set through intuition and collaboration with the thesis 
advisor and were designed to allow subjects to evaluate if they felt an area of identity had 
been affected. Questions were not based on the literature as such, as this is a preliminary 
and exploratory look at whether or not areas of identity were affected. Questions were 
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open-ended with the intention of inviting subjects to explore the topic further. The 
questions were not asked according to category, rather a brief summary of the course of 
treatment was requested and subjects were then asked to give narrative responses around 
areas of identity, concerns, and side effects. At times, clarifying follow-up questions were 
asked based on answers given, but the script was strongly adhered to. 
The interview guide (see Appendix D) was based on flexible method research and 
was intended to garner as much information as possible, which included direct 
observations and context. 
The researcher, the people and phenomena studied, and the inferences made about 
them are seen as part of an open, interactive, potentially fluid situation. The 
credibility of the findings of flexible method studies often flows directly from this 
inclusion of context, of everyday social and psychological complexities, in the 
picture. (Anastas, p.61). 
Themes, concepts, and words from the answers provided were later identified and coded 
and used for content analysis. The sample was obtained using a volunteer, snowball 
method in which participants often referred other eligible survivors into the study. 
Sample 
There were 11 participants in this study. All were women who had undergone 
chemotherapy for the treatment of breast cancer. These women were required to be 
between six months and five years past the end of chemotherapy and 18 years of age or 
older. Recruitment took place via the nonprobability method of snowballing. 
This technique is used either with convenience or purposive samples when there 
is initial access only to a very limited number of identifiable sample members.  
These few people who meet the sampling criteria are recruited, and they in turn 
are requested to identify other people like themselves who would be eligible to 
participate in the study. (Anastas, p.289). 
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The exploratory nature of the study allowed for this method of recruitment as a basis for 
beginning to gather initial data. There were no additional age or race requirements, 
however, the participants were all female, which lent some homogeneity to the sample. 
Selection procedures were only random in that all participants who were contacted 
through the network, met the requirements, and agreed to participate, were included. 
There was no selection bias based on initial conversations with the researcher as to the 
nature of the participant’s chemotherapy experience, thus allowing for any possible 
“negative cases” (Anastas, p.61). At the end of each interview, each participant was 
asked if she was aware of any others who would be willing to be interviewed and was 
welcomed to provide the researcher’s contact information to them. Initial subjects were 
recruited through friends of acquaintances known to the researcher. This allowed for at 
least two degrees of separation between each participant and the researcher. Demographic 
information including age, date of diagnosis and stage of cancer, family history of cancer, 
race/ethnicity, occupation, marital status, and religious affiliation were gathered in order 
to consider data in terms of support networks, lifestyle, and beliefs and to compare the 
data both within the group and to the larger population (see Appendix C). This 
information was gathered via a brief questionnaire that participants filled out immediately 
preceding the interview and after signing the Informed Consent. In the case of phone 
interviews it was mailed out to participants prior to scheduling the interview, along with a 
stamped and addressed return envelope. Interviews were set-up upon return receipt of 
both the Demographic Information Data and Informed Consent forms. 
Four of the interviews were conducted over the phone and seven were done in 
person. All participants were Caucasian and the age range was 34 to 69 years old with the 
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average age being 55. Eight participants were from Colorado, one from New York, one 
from Georgia, and one from Utah. Date from diagnosis ranged from 10 months to 5 
years, with an average of a little over 2 years. 
Risks and benefits were discussed with each interviewee prior to the start of the 
recording process. They were verbally informed that the primary risk of participating in 
the study was that they may experience some degree of emotional stress or trigger and 
that discussing an experience like chemotherapy can be upsetting and make them feel 
vulnerable. They were reassured that they could stop the interview at any time. 
Additionally, the women were provided with a list of mental health professionals, clinics, 
and hotlines that were local to them in the event that they felt the need to talk to someone 
following the interview. This information was researched and gathered by the researcher 
prior to each interview and was on hand in case it was needed. Participants were also 
reassured that all information gathered would be held in confidence by myself and that 
my thesis advisor would only have access to it once all identifying information had been 
removed. It was explained that their names would not be used in the study, they would be 
randomly assigned a number, and identifying characteristics, such as age, would be 
minimal. 
A primary benefit of participating in this study was explained as being the 
participant’s knowledge that her experience and sharing of it could potentially lead to a 
better understanding and system of care for others who have to undergo similarly 
invasive and traumatizing protocols. It was also explained that the chance to process the 
experience and share it with another may provide new understanding about it for the 
participant and may help her to think of it in previously unconsidered terms. 
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Data Collection 
Data was collected through a one hour interview with each participant (see 
Appendix D). Each subject received, reviewed, and signed a copy of the Informed 
Consent (see Appendix B) form prior to the start of the interview and was given a copy to 
retain for their records. A Smith College Human Subjects Review (HSR) committee 
approved the study and all of its materials prior to the first interview (see Appendix A). 
Included in the Informed Consent was information about the nature and approval of the 
HSR, contact information for both the researcher and the HSR committee, and 
information about protecting confidentiality in line with federal guidelines. Additionally, 
information was provided about local resources for participants to contact if they 
experienced any harmful side effects triggered from the interview. 
Quality of life variables including relationships, religion/spirituality, sense of self, 
and worldview were addressed in the open-ended interview. Questions around topics 
such as concerns about chemotherapy before, during, and after treatment, side effects and 
their emotional effects, and any changes noticed emotionally, mentally, or physically 
were included. Face-to-face interviews were conducted in the homes of the participants, 
and over-the-phone interviews were conducted from the home of the researcher. 
Interviews were audio-recorded using a small taping device and later transcribed by the 
researcher. In the case of phone interviews, the interviewee was put on speaker phone and 
recorded using the same device as used with in-person interviews. Each sample was 
blinded by the assignment of a random number to the interview and the removal of all 
identifying information, including names, from the interview transcriptions. The 
 33 
randomly assigned number was given by the researcher, and all information was coded 
according to the number assigned to each interview. 
Data Analysis 
Data content was analyzed for themes with coding based on these themes and 
then contrasted and compared with all of the information as a whole. Themes such as 
emotions, worldview, change in spirituality, and type of symptoms were color-coded and 
charted. As the study progressed and new or unexpected information was gathered, it 
helped to inform other areas to explore with new participants. The complete transcription 
of each interview allowed for the re-reading of the interviews, and further examination 
and comparison of the data. Potential researcher-bias due to previous experiences with 
chemotherapy was addressed through the non-leading and open-ended nature of the 
questions. 
Themes were assigned different colors for analysis and were highlighted 
accordingly as they emerged in each interview. The themes included emotional 
effects/coping/support, other effects/changes, side effects, sense of self, relationships, 
spirituality, worldview, concerns, and causes of the changes. A master list was kept of the 
color assigned to each theme, and each interview was reviewed and coded according to 
these themes and colors by underlining the responses. Each theme was reviewed and 
responses and quotes were recorded on a separate sheet of paper with similarities and 
differences noted in patterns and responses. 
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CHAPTER IV 
FINDINGS 
This chapter contains the findings from interviews conducted with 11 female 
breast cancer survivors who have undergone chemotherapy. The structure of the 
interview was designed to elicit narrative responses that reflected on the changes, if any, 
the participants felt they had undergone as a result of receiving chemotherapy. Areas of 
change included emotions that were affected, physical changes, relationships, worldview, 
sense of self, and spirituality. To gain additional information around these topics, 
participants were asked to reflect back on their chemotherapy experience and to discuss 
topics such as side effects, support networks, and concerns. At the end of the structured 
interview, participants were asked if there was additional information they wished to 
share about the nature of their experience with chemotherapy. 
The data from these interviews are presented in the following order: demographic 
information of participants, side effects, emotional/coping/support networks, physical and 
mental changes, sense of self, relationships, spirituality, worldview, concerns, and causes. 
Participant Demographics 
The sample size for this study was 11, all female. All participants (n=11) 
identified as Caucasian. Christian (n=7), Jewish (n=2), and not affiliated (n=2) were 
selected as religious/spiritual affiliation. The women identified as married (n=7), 
divorced (n=1), single (n=2), and widowed (n=1). Most of the participants (n=9) reported 
that they are still working, while the others (n=2) are retired. Several of the women (n=5) 
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reported no family history of cancer, a few (n=3) reported a family history that included 
breast cancer, and some (n=3) reported a family history of cancer that did not include 
breast cancer. One participant, (n=1) did not report the stage of cancer with which she 
had been diagnosed, a couple (n=2) were diagnosed stage 1, the majority (n=6) were 
diagnosed with stage 2, and a couple (n=2) were diagnosed with stage 3 breast cancer. 
Participants were between 6 months and 5 years from completion of chemotherapy. 
Side Effects 
Participants described a myriad of side effects that they attributed to the 
chemotherapy. All participants (n=11) reported losing their hair, which was the only side 
effect that all 11 had in common. There were varying emotional responses to this loss, 
but all agreed for the most part that, as one participant put it, “it turned out to be a much 
messier process than I would have anticipated. It comes out in clumps. It’s worse than 
having a shedding pet.” Most subjects (n=9) described overwhelming fatigue, which one 
woman described as: 
Profound fatigue where you literally feel like, if you’ve ever had weights from 
working out, like ankle-weights that you carry, felt literally, it was so hard just to 
put one foot in front of the other. It just washes over you. Like, 3 or 4 o’clock in 
the afternoon it’s like you run into a brick wall. You are so dead. You are gone. 
Another subject described the fatigue as: 
Your get up and go definitely got up and went. There isn’t anything that isn’t 
sapping of your strength. And there were really days where I felt like I couldn’t 
crawl out of the bed. I mean, you do, because you think ‘if I don’t get out I won’t 
be able to.’ 
Other participants (n=3) reported insomnia. Most of the subjects (n=8) struggled with 
nausea, but only a few (n=3) actually vomited. One woman stated that her nausea was so 
“horrific…I had, basically from the day I got my first chemo until three weeks (after the 
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last), just constant nausea and puking.” As a result, a few (n=5) described some weight 
loss and (n=6) stated that their sense of taste was negatively altered. One participant 
stated that “anything sweet was really disgusting tasting, it tasted just like I was 
crunching on a sugar bowl.” Another stated “the food was terrible!” while a different 
subject simply declared that “things didn’t taste the way they normally do.” Mouth sores 
were reported by several women (n=4), which one described as “trench mouth” as well as 
dry mouth (n=2). One woman stated: 
As far as I can tell you, I forced myself to eat, I drank this rinse called ‘Magic 
Rinse’ to deaden my mouth and throat so the sores would not prevent me from 
eating. I continued to eat whether I liked it or not. 
For one participant, she recalled her mouth sores as a sort of fluke: 
My first infusion, they did not tell me to suck on ice cubes, so I lost the skin on 
the inside of my mouth and I had pustules all over my face. I was miserable, just 
miserable. My second infusion, the nurse came and hugged me and was almost in 
tears and she said ‘I forgot to tell you to chew on ice. But the day I had you as my 
patient my 93-year old mother slipped and fell, I was late for work. Please forgive 
me.’ So I chewed ice during the orange infusion and I chewed on ice during that 
whole infusion and I never got sores in my mouth again. 
Four respondents reported having significant issues with neuropathy, which 
included pain and tingling in their feet, arms, and hands. 
And as a matter of fact, the doctors were like ‘If you start feeling tingling in your 
fingers you need to take a week off’ because it can cause permanent nerve 
damage. And my fingers started tingling but I was like ‘I don’t want to take a 
week off, I want to be done.’ So now my fingers tingle. But whatever. If I had 
taken a week off I don’t know if I would have gone back. 
Another more common side effect experienced by several women (n=4) was 
described as “chemo brain” or memory and cognitive impairment. All four also stated 
that the effects had lasted to some degree post-chemotherapy. One woman said “I had 
what I would call ‘chemo brain’ it made my mind foggy, so it was hard to keep my train 
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of thought or my focus.” Another woman summed it up by saying “I would have a 
thought come into my head and it would just exit.” Another frequent side effect was 
varying forms of pain (n=5). This included joint and bone aches, headaches, and 
generalized pain, which, for some, continued past the end of treatment. “I have a lot of 
pain that I don’t tell anybody about, but I’m kind of sick of it.” Another described the 
actual pain of the infusion: 
I didn’t have a port because the drugs I was given were brand new and they were 
not toxic to the skin. So I didn’t have to have the port. So it was just like touching 
a hot oven. You knew, they’re putting in the saline, they’re putting in the other 
bags of drugs, and as soon as the chemo hit you knew it because my arm was 
literally on fire. Like you literally, you were fighting back the pain. So that was 
the sensation during. And you were always cold, very cold. You could feel it was 
ice cold and burning at the same time. So it was very contradictory in terms of the 
senses. 
Depression and sadness were another side effect listed by several (n=3) women 
which one attributed to her “listlessness” of not being able to engage fully in her life.  
Dizziness was described by a few (n=3) and one stated that she still struggled when 
rolling over in bed. One woman developed a sore on the bottom of her foot that her 
surgeon “scooped out” while another developed pustules on her face. Another woman 
described her skin peeling so badly that she was afraid “if it keeps going my bone’s going 
to show through.” Two women reported the loss of all of their nails while another one 
simply stated that they had become extremely brittle. Dry eyes, runny nose, skin color 
change, and diarrhea were each described by one woman as minor inconveniences. 
Some less common side effects included one woman’s hallucination-like visuals 
of orange and purple spots in front of her face, slurred speech, and listing gait while 
walking, none of which she felt her doctor was able to explain to her. Sexual side effects 
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were reported by two women, with one of them stating that “the drugs dry you up, 
everything. So that has been really, really annoying. That was a side effect I never knew 
about. It affects your sexuality.” 
Side effects led to more serious problems for two of the women. While one 
woman reported that she was initially thought to have a blood clot that turned out to be 
nothing, another actually did get one, due to her port: 
It was in my arm, my hand turned purple, you know, big swollen, like an elephant 
arm. I was at work at it was pretty scary. They thought it was arterial at first. Then 
they said ‘ICU’ and I thought ‘this is bad and that could kill me.’ I was more 
scared with that than I was actually with the chemo. So it was a result of the 
chemo, but it was more tangible for me to see that this was a potentially deadly 
problem. 
This same subject went on to say that: 
I made it through chemo and then I developed a gall bladder problem and had to 
have my gall bladder out, and I got an ulcer as a result of the chemo and 
developed Gastritis. 
One other subject experienced a rather serious side effect related to her already present 
condition of Super Ventricle Tachycardia: 
And that means every once in a while my heart starts beating very quickly, and if 
I take a deep breath and sit down, it goes away. However, when you have chemo, 
you get your Tachycardia, and you can’t get rid of it. So you end up in the 
emergency room, where they stop and start your heart, you know, within a 
second, in order to make it stop. I had to do that three times. 
Emotional/Coping/Support Networks 
Despite the disparity in marital status, all respondents (n=11) reported feeling that 
they had an adequate emotional and physical support network. What this network looked 
like for each of them, however, varied greatly. One woman stated that her husband was: 
Just so wonderful and precious and kind and just helped me get through it so 
much more, and I have wonderful friends from my church who decided on their 
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own, when I started chemo, they came every Tuesday morning. So I was here at 
home with our family, our daughters and granddaughters and grandsons. 
Like most of the participants (n=9) this woman never drove herself to one of her 
infusions, rather, she always had a ride from a friend, family member, or neighbor. In 
contrast, two women drove themselves to every treatment and sat alone during them. 
This was a journey I was making by myself. I’m a widow, I do have two sisters 
and an 86-year old mother who doesn’t understand why I’m sick. And both my 
sisters have spouses and children and grandchildren and they both work full time. 
It wasn’t like they were there holding your hand. 
The other woman who went through it alone stated that: 
I thought this is like a new experience cause I’m learning all this different stuff. I 
thought ‘I hate to be the guinea pig’ but someone’s gotta do it, you know? And I 
felt that it was better that I got it than some young mother with children, like that. 
I thought, cause I’m single, I’ve always been single. I’ve got brothers and sisters 
and if something were to happen to me it would be no big deal. Well, it would be 
a big deal, but you know, not like a family. 
Despite going through each infusion on her own, each of these two women expressed that 
they absolutely felt that they were emotionally supported by family members and friends 
throughout the treatment. “My family members and friends were absolutely awesome, 
including my neighbors. Everybody was very supportive. I never went to a chemo 
appointment by myself.” All of the married women (n=7) stated that their husbands drove 
them most of the time and sat with them, and friends drive them the other times. 
My husband was distressed just generally over the whole situation, I don’t think 
men deal with, particularly if it’s a female-oriented problem, and he was just 
scared to death about what was going to happen and he was going to wake up 
some morning and I wasn’t going to be there. 
One woman made a cross country move halfway through her course of chemotherapy. 
Her husband was her “100% caretaker” before the move, but due to work conflicts, she 
found herself driving herself to treatments in their new home state. Despite the 
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overwhelming amount of support that all women felt they received during treatment, one 
said that: 
I remember feeling really alone, even though I had tons of friends, and my 
husband and my family were really supportive. I just felt like no one knew exactly 
what I was going through. 
Emotional effects experienced from the impact of undergoing chemotherapy were 
expressed by most of the women (n=9) and two of the women described it as not being an 
emotional time for them. One stated that “you really don’t know what you’re getting into, 
so ignorance truly is bliss.” Another woman said both that “I can’t imagine not doing it” 
and “well, you know, emotionally it’s terrifying. I mean, you, if you think about it too 
much you’d be in a padded room.” Many women expressed the trauma of the experience, 
with one stating “it is a traumatic time, no matter what you say or do, it’s traumatic.” 
When asked specifically what the side effects had been like emotionally for her, one 
respondent said: 
Most of them were pretty scary, like when I had at least three different anti-
nausea treatments, and it was the third treatment and none of them were working, 
and I, plus I did lose my appetite. So I hadn’t eaten much, and I couldn’t even 
tolerate drinking any water at that point, so that was pretty scary. I didn’t want to 
have to go to the hospital because I was throwing up from chemo. 
Two of the women found the loss of their hair to be among the most difficult side effects 
for them emotionally. One woman said: 
If anyone had ever said, you know, five years ago before I had breast cancer, that 
it would be harder for me to lose my hair than it would be to lose my breast, I 
would have told them ‘you’re absolutely crazy.’ I can honestly tell you that it was 
harder for me to lose my hair than it was for me to lose my breast. 
When asked why this was such a traumatic side effect, another woman put it this way: 
You’re never really, in my opinion, emotionally prepared for that. Why your hair?  
Because, in my mind set, it is the physical attribute that you’re sick. Nobody 
knows by looking at you ‘oh, you’re sick.’ No hair? Cancer. 
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When asked if she felt this was directly related to the chemotherapy she replied: 
Exactly. Because if you have radiation that would not be the case, or if you had 
cancer and didn’t have either one, that would not be the case. Correct. That is 
absolutely correct. So it is the only outward physical attribute and it was literally 
coming out in clumps. And I was horrified. That was the only time I cried. 
Despite varying reasons as to why, and to what extent, the chemotherapy elicited an 
emotional reaction, the majority (n=9) of the women solidly agreed that there had, in fact, 
been emotional consequences related to the treatment. 
Universally all (n=11) of the women agreed that they had made the correct 
decision and did not regret undergoing chemotherapy. “I think I would be a nutcase (if I 
hadn’t had it). I think I would be wondering every single day, did they get it all out? Is it 
floating around in me?” One woman reported having had such inconsequential side 
effects that she had questioned at one point whether or not she had ever really had cancer. 
The others (n=10) however, definitely noticed they were affected. One woman who did 
not report having any emotional changes or struggles stated that: 
It was not exactly a party, but I had zero fear sitting there. I was not afraid of what 
was going into my body. I have a friend who was afraid that all the drugs were 
going to kill her. And if you want to look at it that way, you are taking poison, 
and I would expect that you would be a freaking, nervous wreck. But I just 
pictured it as my get-well juice. You have to if you’re going to take that junk…or 
you would not be able to sit in that chair, it would be like a lethal injection. 
All of the women (n=11) also agreed with each other in that they felt they had all chosen 
the most aggressive form of treatment available and had done all that they could to ensure 
that it would not return, despite concerns they may have had about the chemotherapy. “I 
wanted automatically the best chance to live. You know, I have three kids at home.”  
Another said “well, I really didn’t want to do it, but when he (the oncologist) told me that 
was the treatment that he would suggest, I didn’t really think twice.” Another put it as 
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doing it “for me and my own emotional wellbeing, I had to do everything that was 
possible.” One participant had a dramatic moment that had a profound impact on her, yet 
she never wavered in her commitment to continuing: 
The Adriamycin/Cytoxan, they call it the Red Devil because it’s actually red. 
When the nurse came to inject it into my IV, she had to put on, basically, 
chemical gear. Two pairs of gloves, the mask, and the extra gown. For me, my 
husband and I went ‘this is not good.’ She has to put all this stuff on because it 
can’t touch her, but she’s going to inject it into me. 
One woman had a distinct moment of wanting to quit treatment, but agreed to continue 
after discussing it with her husband: 
It hit me that this was real and it’s not going away and it’s a long haul. And I 
didn’t want to do it. And I told my husband I didn’t want to do it anymore, and we 
kind of had a deal, cause I had always said ‘if I ever got cancer I would never do 
chemo, that’s my outlook, that’s my fate, blah blah blah.’ So when I agreed that if 
I was going to do it all, we kind of contracted in a way that I was doing it for him. 
So, then, four weeks later I was like ‘there’s no way I’m doing this again. This is 
ridiculous’ and so he said ‘let’s go back to the doctor and see if there’s more stuff 
they can give you for the nausea, try it one more time and if it’s this bad or worse 
we can decide what we’re going to do. 
As for coping with the emotional side effects of going through chemotherapy, the 
women reported a range of skills and resources. All of them (n=11) reported that while 
actually receiving the infusion, they had no interest in being social with people in the 
room outside of their support network. Many (n=8) reported that they slept through most 
of the infusions as there was Benadryl added to their cocktails. One woman reported that 
it was a nice time for her to catch up on her reading. “I came (alone) because I wanted to 
read my book. I never have time to read, now’s a good time to read. I don’t need a bunch 
of people around watching me get this, you know?” A few women (n=3) felt that it was 
important and helpful for them to maintain an exercise regimen to help them cope. 
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Lingering emotional side effects remain for most (n=9) of the women. These 
range from the sentiment that they are “done” and will not ever do chemotherapy again, 
to the “voice of paranoia” that most (n=7) of them described as being ever present in the 
back of their heads. These women hope that someday they will not attribute every ache 
and pain to a possible reoccurrence of cancer. Two of the women also described lingering 
emotional effects upon seeing the chemotherapy room again during subsequent doctor’s 
appointments. “Now when I go to my doctor’s and I catch a glimpse of that room, it 
makes you feel funny. I think my husband, too.” The other woman stated that “I can 
remember the smell of the chemo room and I can remember the smell of walking into the 
hospital. I don’t remember going home.” 
Finally, several women (n=4) talked about the difficulties and emotional impact 
of not feeling like their doctors were forthcoming with information. One said that “what I 
resented the most was my oncologist and my nurse not saying to me how hard it would 
really be.” Another said, “I will tell you one thing, there’s not enough information given 
to chemo patients, I don’t feel, by their doctors. The doctors are very bad about giving 
you information.” Another expressed anger about this, saying: 
I’m angry about that because I know I’m not alone in this. And they give you this  
song and dance when you’re a deer in headlights. You really don’t know a darn 
thing about what they’re talking about. I think that needs a great deal of re-
vamping. 
The fourth woman explained this lack of information from another angle, saying that: 
I think that one of the things is that they don’t tell you a lot of the things that are 
going to happen. And there’s a good reason for it. The doctor said ‘I’ll be honest 
with you, if I told you what was going to happen, you wouldn’t do it.’ I think, it’s 
a very viable point of view. It’s not pleasant. I would have done it, but I know 
other people who wouldn’t. 
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While all the women agreed that they had made the best possible decision for themselves 
at the time, the emotional consequences and repercussions were different for each of 
them. 
Physical and Mental Effects 
All of the participants (n=11) reported some kinds of physical consequences from 
the chemotherapy. Most of the women (n=7) stated that while they felt slowed down by 
the chemotherapy, they didn’t feel overwhelmingly terrible. 
I pretty quickly realized I could work and maybe school, or maybe a little 
exercise. It put limits on me and made me re-prioritize what activities I wanted to 
get done everyday and that sort of thing. But I’ve definitely seen people way 
worse off. 
One participant said that she “wasn’t really fatigued until it was kind of all over. And I 
was thinking, ‘I don’t know if I’m fatigued or just lazy now.’” Another said she felt she 
“has less stamina now” and that “I feel like I’ve aged more than I would have if I had not 
had (chemo).” One of the younger women said she had told her doctor “I think I was born 
at 100 and now I’m 68 because I have a lot more in common with 68 year olds” due to 
the physical consequences of the chemotherapy. 
The remaining women (n=4) reported more severe and persistent physical effects 
from the chemotherapy. These four women also reported much more difficulty with 
treatment. One described it as: 
Well, physically it was kind of like crawling out of a hole everyday. Um, you 
know, once you got up on level ground it seemed a little bit better. But the idea of 
lying in bed and you think ‘well, I have to get up and take a shower.’ It was 
almost kind of more than I can bear thinking about. But once you’d gotten 
yourself out of bed and you’d turn the water on and you get in there and think ‘ok, 
this is gonna make me feel better.’ There’s a lot of talking to yourself and kind of 
self-motivating. I’m not one too…I don’t do sick well. 
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When asked about negative physical changes that had resulted from chemotherapy, one 
woman declared, “you know, you get negatives, but they become very trivial compared to 
going through chemo.” 
Exercise was a primary coping strategy for dealing with the side effects for a few 
(n=5) of the participants. One told a story about a local radio show talk host who had 
been diagnosed with breast cancer shortly before she had been and how she had worked 
out everyday and had still managed to do her daily radio show. 
Before that I don’t think I realized that you could keep up a pretty decent level of 
activity and then since then I’ve read that it can really help you tolerate the whole 
experience better, if you can even just go for walks, or some physical activity. 
She found this example to be very inspiring for her and it helped motivate her to keep up 
with her own exercise program, which she credits with keeping her side effects from 
being much worse. Another said that her perspective on exercise was “it could have been 
worse, maybe I could have been a lot sicker.” She maintained a schedule of running 
everyday that she was able and skiing as often as she could. A younger participant was an 
aerobics instructor and said she simply reduced her teaching schedule to three classes a 
week while undergoing treatment. She felt that this helped her cope physically and 
emotionally, however, she also believed that she was still suffering from some of the 
fatigue-like side effects: 
Our lives are crazy busy normally, but I definitely feel like there’s a big rock on 
my back. I still go 100 miles an hour, but I’m just like dead tired every night. So I 
guess this is my new normal, but I can’t remember what my old normal was. 
The women who maintained their exercise schedules (n=5) all agreed that this was a great 
help to them. One of the non-exercising women admitted “I don’t exercise, I never have, 
I never will. But I would have people come over and walk with me because walking is so 
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good for you, and I hated that more than life.” In addition to exercise, nutrition was also 
cited by several ladies (n=4) as being a way for them to cope with chemotherapy. One 
said, “I forced myself to eat more nutritiously than anyone you’ve heard of in your entire 
life. Spinach, collards, all kinds of really good things, everything I know to be 
nutritiously good for the body.” These four women all agreed that food became a main 
way for them to respond to the treatment. One put it this way: 
I read everything on the Internet, got as much info as I could cause I think when 
you have info you don’t worry as much about that type of thing. So I looked at 
what chemo does to your body, about physical therapy, about food, diet 
supplements, I just looked up everything. And then I felt ok about it. 
Being mindful of eating healthfully and nutritiously was a way in which these four 
women maintained a sense of control about what was happening to their bodies. 
One of the most persistent side effects reported by several (n=5) participants was 
a change in cognitive functioning, or “chemo brain.” While not all of the women 
mentioned these effects, and several (n=3) specifically stated that they had not noticed 
any cognitive changes, ‘chemo brain’ was a term recognized by all of the women (n=11). 
One woman cited her continuing issues with memory, processing, and “lack of clear-
headedness” as affecting her job and relationships with her co-workers. Another said, “I 
definitely feel slower. I have to pay attention to what I’m doing or I get scatter-brained.” 
One of the younger women said, “I always say, even now, I have chemo moments like 
brain farts or early Alzheimer’s. I’ve noticed that I never used to have them.” Another 
described how it affected her daily: 
I really don’t feel that I’m back mentally 100%. My short-term memory is coming 
back little by little but it’s not as sharp as it used to be. Sometimes I can’t get the 
right vocabulary words out, I misused a lot of words right after. There are a lot of 
words that just sort of slipped through my head and it really bothered me. I’d 
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explain to people ‘I’ve got chemo brain and I’m not really thinking correctly.’ If I 
forget an occasion I just send a card late and say ‘sorry, it didn’t register with my 
chemo brain.’ 
The three women who reported no cognitive side effects all agreed with one another that 
they had, at some point during treatment, feared that they might experience it. 
For five of the women, hair loss was identified as one of the most troubling 
physical side effects. One woman said that when she lost her hair two days prior to when 
her doctor told her she would that it was the only time of her entire illness that she cried. 
Another woman felt it was hard for her because, “for a woman it’s a hard thing when all 
your hair comes out. Cause when you have a husband or a family, or a boyfriend, you 
know, you just, it’s a hard thing.” Another woman described the loss of her hair being the 
outward sign to the world that she was sick: 
I could sort of maybe say ‘it’s not that bad, it’s not that bad.’ But when I lost my 
hair I had to say to myself ‘this is bad, this is really bad. You’re sick and this is 
life threatening.’ You know, all the things I already knew, but maybe that hair 
loss made it all that much clearer. 
Another put it this way: 
Well, I guess, while I still had my hair no one knew so I could fake it. But once 
your hair falls out you’re a totally different person cause everybody knows, they 
wonder or they look at you differently. 
When talking about deciding to shave her head, another participant said: 
I went one day, shaved my head, and that was kind of liberating for me. And that 
was just kind of getting over that hump of ‘you’re gonna lose your hair, you’re 
kind of losing it, now it looks horrible’ and then you just shave it and it’s done. 
While all (n=11) of the women lost their hair during chemotherapy, several (n=6) said 
that it had re-grown in a different way that they didn’t like. One described it as “crazy 
curly” while another said: 
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I came back with chemo curl, I’m part of the 70% where your hair comes back 
like, different. I hate it, I hate it short, I hate it curly. It came back bronze, black, 
platinum, white. I’ve been blonde for almost 60 years, I didn’t know who I was in 
the mirror. 
One participant looked at the loss of her hair in a more positive light and said, “I got 
upset when I knew I was gonna lose my hair. But my hair was so bad anyways, I thought 
maybe I’ll get some new!” One of the younger women was upset not so much at the loss 
of her hair, but at the hormonal changes that resulted from the chemotherapy and led to 
“random hairs and adult acne.” 
Two women specifically mentioned that they felt they had sexual side effects that 
they had been unprepared for. One felt that her “sex drive is a lot lower” and the other 
said: 
Everything hurts, and that is just something that nobody tells you. And I have, 
they just say that you atrophy in that area, and I believe it. The drugs dry you up, 
everything. So that has been really, really annoying. That was a side effect I never 
knew about. It affects your sexuality. 
Both felt that this particular side effect was a direct result of the chemotherapy. 
Finally, several (n=3) of the women felt that there was no reason for them to have 
gotten breast cancer based on their healthy lifestyles. While two of them recognized that 
their good health going into chemotherapy had probably made the treatments more 
tolerable for them, all three were angry and confused at having to get it. 
You know, statistically, I shouldn’t have had breast cancer. You know, I didn’t 
smoke, I didn’t drink, I was not overweight, there was no history in my family. I 
shouldn’t have had it. But I got it. 
Another said: 
I kinda went through the stages of grief, just like they tell you, you will, I was 
shocked, anger, I mean, I couldn’t believe it was me cause I’ve run, like, ten 
marathons before. I mean, I like cookies, but…cookies shouldn’t give you cancer. 
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For these women, having to go through chemotherapy was particularly hard in that it 
seriously affected their belief that they had been living lives that protected them from 
such harsh realities. 
Sense of Self 
Sense of self was explained to the participants as including the way in which they 
view themselves and their identity. The most significant response given by the 
participants was that most of them (n=7) felt that priorities had become even more 
important to them in their lives. One described this as feeling like “things closer to home 
have become more important” and another said: 
I did come out of this realizing, one thing I have done and I will continue to do, is 
we don’t put things off. Like if we talk about doing something, going somewhere 
or doing something, if we can afford it and can find the time to do it, we do it. We 
don’t say ‘we’ll do it in two years.’ We don’t tend to do that anymore. Life has 
become very precious. 
Another put it as: 
Your whole outlook on life changes. The little things in life become very 
important, like seeing the flowers and the trees, the birds singing and all that. 
Grandchildren smiling. 
One of the younger participants felt like it had helped to see a new perspective on her 
life: 
I always really appreciated life and I always knew that tomorrow could be 
different, I always had a respect for the fragileness of life, it did reinforce and 
help me become clearer on what I want out of life. But it does make you struggle 
with that a bit, too. It seems like ‘how do I prioritize all these really important 
things and make sure that happens?’ 
One woman felt that her perspective on herself had changed in such a way that she felt 
the importance of becoming a more giving person in order to lead a more meaningful life. 
She said, “life is not all about me. It’s about what you give back and if I was to die 
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tomorrow, would I have made a difference?” Several of the women (n=5) also described 
part of the changes in their self-identities following chemotherapy included them actually 
liking themselves better. One woman said: 
I think I’m definitely a different person. You have empathy now. I was probably 
one of those people who would stare at the lady who’s hair was falling out, and 
now I when I see them I have not sympathy, but empathy. I’ve been there and 
done that, and it’s not just the hair, it’s everything that goes with it. But I think I 
am much more attuned to other people than I ever was. Maybe I’m just finally 
growing up…but it definitely gave me perspective. 
Another woman came right out and said, “I probably like myself better because a lot of 
the things that are kind of superfluous that meant something before, it doesn’t matter. It’s 
just another day.” A woman who had particularly bad side effects and had said that “if 
you had asked me five years ago ‘would you have chemo?’ I would have said ‘oh no, that 
stuff will really poison you’” went on to describe herself as being “tough as nails” in the 
face of her treatment and side effects and attributes much of her progress to this positive 
attitude about herself. Several (n=4) of the women specifically described themselves as 
being “strong” during treatment and one said that as a result of that strength she realized 
“it’s quite incredible what you can get through.” 
Some of the participants (n=5) really felt like their sense of self and identity was 
really shaken or different as a result of their chemotherapy experiences. One said, “I think 
I was shaken for awhile” while another described her sense in a bit more detail: 
It’s definitely been affected, but I think more, the lasting effects of the chemo I 
would say are, it’s my frustrations with my memory and being frustrated that my 
brain doesn’t work as efficiently as it used to. But, so that affects my sense of self. 
I don’t think I’m as articulate as I was. 
When asked who one woman considered herself to be in lieu of having undergone 
chemotherapy, she responded by saying, “I don’t want it. I don’t want to be a part of it, I 
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don’t want it to be a part of me. Leave me, go away.” Three of the women also described 
distinctively negative consequences that they felt and attributed to the chemotherapy. One 
said “we have cancer, we will always have cancer. There’s no guarantee that there’s no 
cell in our bodies that still exists.” Another phrased it as, “people comment continuously, 
you must be normal and you want to scream cause you’re like ‘I’m not normal!’ The new 
me. And I’ve read about it, but you can’t tell anybody.” This same woman described 
these feelings in relation to her hair growing back and people assuming that was a sign of 
her recovery and completion with the effects of chemotherapy. Part of the fear related to 
changes in self had to do with the concern related to the chemotherapy not having worked 
100%. One of the younger women talked about how she and her husband had always 
planned to adopt a child someday: 
The other piece is that I don’t know if in good conscience now I should adopt, 
because I don’t know what…and I found myself struggling with that. I certainly 
wouldn’t want to adopt a child and then die. 
In contrast, four of the interviewees felt that very little, if anything had changed 
about their self-identities. When asked about possible changes, one said, “not at all. Not 
even slightly. As a matter of fact, if anything, I realize I have more self-confidence 
because I realize that I am not a breast.” Another attributed the lack of change to her 
tremendous sense of self-worth, saying, “I have an, I must have a gigantic ego. It was 
‘this is what is happening to me, I’m still who I am. It’s not happening to my spirit.’” 
All of the women were very sure in their feelings of whether or not undergoing a 
treatment as intense as chemotherapy had affected who they thought themselves to be. 
Despite full agreement from all of them that they would not have changed their decision, 
not all agreed that they had made it through unscathed. 
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Relationships 
Most of the participants (n=6) felt that they had relationships that had grown 
stronger or deeper as a result of them having gone through treatment. One of them 
expressed that her relationship with her mother was the most profoundly affected by her 
experience. She said: 
I said to someone once, ‘man, if I had to go through that again now with my mom 
being how she is now, I might do it again!’ She comes to visit and she’s helpful 
and pleasant. My relationship with her has definitely gotten closer. 
Another felt that her relationship with her husband had grown much closer since her 
chemotherapy, “my husband and I have always had a wonderful marriage and been close, 
but we’re even closer now.” Others expressed the change in their relationships by 
comparing them to the people they felt they were no longer close to: 
I think that by and large it brought me closer to most people. There are a few 
people, some people just cannot handle the illness thing. And the obvious 
problems that you have from it, it’s more than they can…but no one close to me 
was like that. 
Another described it as: 
I’ve probably embraced the relationships with the people who gave me positive 
energy and kinda let go a little bit of the people who had negative energy. So, the 
positive relationships have gotten stronger and the negative ones I’ve tried to get 
rid of. 
Another woman felt that the experience had brought her much closer to her kids and that 
had improved their relationships significantly. One woman saw her experience as being a 
positive one for her relationship with her husband due to the fact that he was scheduled to 
deploy to Iraq and instead received a compassionate reassignment back home. She said: 
It’s so funny, we kid with each other, I say ‘if I had to do it all over again I would 
if it meant you didn’t have to go to Iraq’ and he says ‘I’d go to Iraq if it meant you 
didn’t have to go through it.’ 
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Some of the women (n=3) felt that there had been no real significant changes in 
any of their relationships. While one described this as being the case, she also felt at the 
same time that “I don’t know if it deepened it, but it made me more aware of none of us 
know how much time we have left, so make sure you connect.” In general, these three 
women felt that their relationships had proceeded through their treatments without many 
effects. One participant reported that this was mainly due to the fact that she had adopted 
an attitude of her treatment being a “non-event” and that she would not allow it to affect 
her loved ones. 
Finally, three of the women agreed that they had negative consequences in some 
of their relationships during and following treatment. One of these women was one who 
felt she had grown closer to her kids, but at the same time felt it had strained the 
relationship with her boyfriend. She said, “my boyfriend says I’ve changed. He says that 
definitely I’ve changed since going through all that. I don’t know that it’s a positive thing 
in his eyes.” She indicated that she had much more uncertainty in her relationship with 
him than she had prior to treatment. She went on to describe a time when she had almost 
been hospitalized for a serious side effect and: 
I remember that night, particularly, my boyfriend was watching the news to see 
what the weather was like the next day so he could play golf and I, that was 
disturbing to me. I thought, ‘I don’t even know if I’m going to wake up tomorrow 
and you’re worried about the weather so you can play golf.’ 
Another woman said that her fiancé had actually broken up with her before her treatment 
began. She said, “he just left. He brought me home from the hospital and just left.” She 
felt that this was due to his discomfort at seeing her go through chemotherapy and face all 
the potential side effects. The third woman who felt that chemotherapy had negatively 
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affected her relationships felt that her development of “chemo brain” had adversely 
affected her performance in the workplace, and thus also her rapport with her colleagues. 
She said, “I would say, it affected my relationships with a couple of people I work with in 
a negative way.” She went on to explain how this had made her workplace a more 
uncomfortable place for her to be. 
For the most part, the women’s relationships were not harmed in any way, and 
many were described as “deeper”, “stronger”, and “closer” as a result of the 
chemotherapy experience. 
Spirituality 
The women in the study varied from Christian (n=7), Jewish (n=2), spiritual 
(n=1), and atheist (n=1). All but one of the women (n=10) felt that religion played some 
part in their chemotherapy experience in helping them to cope and process. Eight of the 
women stated specifically that religion or spirituality were a great support for them and 
helped them manage their treatments better than they would have otherwise. When 
talking about whether or not her relationship with God had affected her during treatment, 
she said: 
I think it made all the difference, it really did. I so often thought ‘if there was 
someone who couldn’t turn to God in a time like this, how could they possibly 
come through it without a lot of emotional problems? I think I would have felt 
lost, I would have been afraid, I think I would have had extreme fear. 
Another woman just expressed it as, “in terms of recovery it helped me to know that there 
was some greater being that your thoughts could turn to.” One participant talked 
specifically about how her religious beliefs helped her during her infusions: 
I got a (feeling) of totally being levitated by God. I have a very strong religious 
background, so I had absolutely zero fear whatsoever going into the infusion, zero 
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fear while I was there, and zero fear during the time frame. No fear. I just felt that 
God was lifting me up. I sat in a chair, if I started to get nervous I just said a 
prayer, ‘Jesus be with me, comfort me, let me feel your arms around me.’ And 
that got me through. 
Another woman simply stated that “I probably believe more now than ever that God has a 
plan and regardless of what you do His plan is gonna follow through.” For these eight 
women, religion and spirituality were seen as absolutely crucial in their journey through 
chemotherapy. 
Two of the women felt that their spirituality increased while undergoing 
treatment, while just one of them saw this as being integral to her recovery. One said, “I 
think it increased my recognition for the need for some kind of spirituality” while the 
other started attending church regularly. She said: 
I definitely felt a connection, more than I had, I just really identified and the 
things that the pastor said and does continue to affect me more I think than they 
used to. I think I needed that spirituality at the time, I think I still do, you know, to 
understand it. 
One woman expressed that she felt that it had made her more “thoughtful” about 
religion and spirituality. She said, “I haven’t really decided how I’m going to take it and 
where I’m going, I do find myself thinking about it much more than I did before.” The 
woman who identified as atheist said, “I actually don’t believe in God, but I didn’t 
believe in God 20 years ago, so it has nothing to do with this. I didn’t look for help 
anywhere but right here.” All of the women used their spirituality, or lack thereof, as a 
way of coping and processing their experiences. To each, it was a topic that bore at least 
some thought. 
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Worldview 
Worldview was defined in the interview as having to do with one’s sense of safety 
and place in the world, view of world events, and level of interest in happenings around 
them. All but two (n=9) of the participants agreed that their worldviews had at least been 
affected by their experience of undergoing chemotherapy, but there was a great 
divergence in what ways it was affected. Four of the women felt that they had grown 
more interested or sensitive to world events. One stated this simply as being “more 
interested in what’s going on in the world, instead of less” and another put it as being “a 
lot more sensitive to other people’s needs now.” The other two of these four women felt 
that it had increased the level of their interest in finding a cure for cancer. One said: 
I think I appreciate more then ever how much time and money the drug 
companies have put into research. And I’m grateful there is such a vocal breast 
cancer lobby, because I do think that has an effect on how much time and money 
and research gets focused on breast cancer. I’ve always appreciated the research 
and development aspect of the drug companies and universities, but that 
appreciation definitely increased. 
Of the remaining women (n=5) who felt their worldviews had been affected, one 
felt that she now worried less about issues like politics than before, saying, “I might have 
dwelled on it more before, and I do not dwell on it anymore.” One woman felt it had 
given her a “sense of a loss of, I don’t know if safety is the word, but you get a sense of 
your own vulnerability.” Another woman found herself questioning humanity and 
peoples’ actions more than she had before. She said: 
I think that you look at the way the world is and you really, I found myself 
wondering why people were actually trying to kill one another when there are so 
many things that can kill them. Why work so hard? It just doesn’t make much 
sense to me. 
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Another woman felt her worldview change in that she was more able to let things go than 
she had been able to before. She felt that “at some point I had to say ‘gotta let go, gotta 
let go’ and let these things take place.” Finally, of the five women who felt their 
worldviews had been affected by chemotherapy, the last woman said that “the way my 
worldview was when I was sick was about me” and when asked if it was different since 
completing treatment, she responded, “oh God, yes. I’m back to me.” This last woman 
did not feel like her change in worldview had a lasting effect and that she was able to 
return to the way in which she had previously understood the world. 
Two of the women felt that their worldviews had not changed at all as a result of 
going through chemotherapy. One simply said it is “pretty much the same” and the other 
felt that “it has helped me be even more empathic, and I always thought I was pretty 
empathetic. I think it’s just reinforced that worldview.” For the majority, there was at 
least a small shift in how they thought about the world in some ways. For the others, it 
either reinforced or didn’t affect these views. 
Concerns Before, During, and After Chemotherapy 
Participants were asked about their concerns about chemotherapy in a three-part 
question. Concerns they had before their first infusion, during their course of 
chemotherapy, and since the completion of chemotherapy were discussed in the 
interviews. The women expressed a range of responses for all three of these time periods. 
Before 
The most common (n=3) concern before the beginning of treatment was how 
family and loved ones would respond to it. One participant said her concern was “how to 
take care of my husband. I wasn’t worried about me, I told him I was going to be fine. I 
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was so worried about my husband and family.” Another woman was worried about how 
it was going to affect her children while the third identified worry about her children and 
about what the effects of the chemotherapy would be on her body. This third woman, 
plus a couple of more (n=3) were concerned with how the treatments would make them 
feel. One was concerned that “I would be throwing up around the clock and that it would 
probably kill me” and another focused on not wanting “to wind up in the hospital” due to 
sickness. Uncertainty and not knowing about what was going to happen were identified 
by two of the women as their greatest concern. One said, “I didn’t have any idea what it 
was going to do to me, or how I was going to feel” and the other stated that it was “the 
uncertainty of it.” This latter woman also expressed concern about having to delay the 
onset of chemotherapy due to a cold she had gotten and felt anxiety at the thought of 
having to delay treatment and remain in a state of not knowing. 
One woman was very candid in her admission that her greatest concern before the 
onset of treatment was “hair loss. I mean, I was certainly concerned about how I was 
going to feel, but that wasn’t my biggest concern. I would have to say that it was hair 
loss.” Another participant worried that the treatment “wasn’t gonna work” and the 
remaining women (n=2) felt that they had no concerns before the onset of chemotherapy. 
One of them said, “honestly, I didn’t have any concerns about the chemo, I just felt like it 
was something I needed to do and I would just go with it.” 
During 
Concerns that arose during the course of chemotherapy also ranged among the 
women. Two women were worried about the pain and sickness they were experiencing. 
One of these women found it very difficult to manage her nausea during the treatment 
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which caused anxiety for her. The other woman said that the pain of the infusion itself 
was so intense that she described it as “a horrible burning sensation.” Two more of the 
participants said that one of their biggest concerns during their infusions was that they 
could keep going and continue the course of treatment. One put it as “keeping my head 
above water, keep going, day-to-day” and the other woman said to herself “alright, suck 
it up and go do it because you have to do it and it’s the right thing to do.” Another 
woman said that, while she only had four infusions and none were particularly bad, she 
was worried each time that the next one was going to be the one that had a negative effect 
on her. She said, “I was worried that maybe the first one wasn’t bad, if that’s all there is 
to it then no problem. Then I thought, well maybe the second one, maybe they’ll get 
worse each time.” Another participant found herself most concerned about “what it might 
be doing to my body, it might be damaging my heart, so I was careful.” Another woman 
was primarily concerned with fatigue during her course of treatment, saying that it was 
“the kind of fatigue I’ve never experienced.” For another woman, her biggest concern 
was that the chemotherapy “wasn’t gonna work” and she would have to face the problem 
again. One woman expressed great concern over her family, saying, “they were so 
worried about me. I hated that.” However, two of the women said that they felt they had 
no concerns during the course of their chemotherapies. One said: 
I really, you’re so focused on, sometimes the moment, I didn’t really have that 
many concerns, and I actually would tell people, through a lot of it, there was a lot 
of peacefulness to it because you didn’t really think about all the trivial things you 
normally think about. I was in the here and now, in a strange sort of way it was a 
very peaceful sort of experience. 
Overall, most of the women struggled with at least one concern during the course of their 
treatments. 
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After 
Concerns following the end of treatment were on a much shorter range than those 
preceding and during. The great majority (n=8) of the women expressed some fear since 
the end of chemotherapy of a recurrence. One woman put it as “when’s it going to come 
back” rather than ‘if.’ There was a general understanding amongst all of the women that 
if their breast cancer returned, it would be metastasized and prove much more difficult to 
treat than the original occurrence. When talking about whether the chemotherapy had 
really worked, one who had already had a recurrence said, “I pray daily that it did. It’s the 
kind of thing where you really don’t want to think that there’s a possibility.” Another 
woman had already experienced a recurrence and felt that “my biggest concerns have 
shifted, before I’m sure I worried about a recurrence. And now, it’s highly unlikely to 
recur (just) as breast cancer. Just a recurrence. Anywhere.” One woman said that the 
thought of recurrence “plays into everything,” particularly around doctor visits. Another 
woman put her concern as: 
That it didn’t work, that it will come back. I think it worked, it served its purpose 
for the round that I’ve been through, but did it kill everything and is there any still 
floating around that’s going to show up at some point? 
For two of the women, recurrence was not their main concern. One was struggling 
with how her hair was going to look as it grew back in, while the other woman was 
struggling with the thought that ‘chemo brain’ might come on in a delayed fashion for her 
and affect her job performance. Only one woman said that she had no future concerns.  
She said simply, “I don’t have any. I’m done. I swear to God.” 
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Causes 
Towards the end of the interviews, the women were asked to reflect back on their 
experiences and evaluate what they felt had caused most of the changes and effects that 
they had discussed. Two of the women very clearly felt that the chemotherapy itself had 
the most profound impact on them. One felt that “categorically” she could isolate the 
chemotherapy as the cause of all of her struggles, mainly because it was the thing making 
her sick. She said: 
For me, it was a continuum, you don’t like pretty much everything being done to 
you. In my case they all just kind of came together, but it was the ups and downs 
that would give you back your life for awhile. And you might find that is what is 
good about chemo, you’re not locked away for six months in despair and pain, 
and whatever. That instead you are able to be back in the world and everything. I 
really, the chemo part of it, I can isolate it easily, it was so isolatable. 
Four of the women felt that the diagnosis of breast cancer was the cause of most 
of their distress and the psychological and emotional impact. One felt that it was the 
diagnosis “because it came completely out of left field.” For these women it was the 
moment of being told they had a life threatening illness that had the most profound 
impact. Their courses of treatment were secondary to this moment and its meaning. 
Five of the women felt that it was a combination of both the diagnosis and the 
chemotherapy that had the greatest impact on them. One said, “I don’t necessarily think 
you can isolate them out. It just becomes so complicated.” Another said “I can’t say that 
chemo itself was the reason why I look and think a little bit differently and why I tend to 
be impatient with people who focus on minutiae. I do feel it’s a function of the entire 
process.” For another woman, the diagnosis led to an emotional reaction, but the effects 
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of the chemotherapy had so many physical side effects that she felt herself have a strong 
emotional reaction to it as well, making it impossible to distinguish between the two. 
Summary 
This chapter has presented the findings from 11 interviews conducted with 
women who completed a course of chemotherapy for the treatment of breast cancer. 
There were many themes that emerged in several areas, while in others, many of the 
women described very unique experiences. Universally, participants agreed that 
chemotherapy was the correct course of treatment to undergo in their treating protocols. 
Not one of the women stated that she wished she had not undergone it, although many 
expressed great concern at its effectiveness. All agreed that they felt they would be either 
terminally ill or dead if they had not undergone chemotherapy. 
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CHAPTER V 
DISCUSSION 
The objective of this qualitative and exploratory study was to look at possible 
links between the experience of undergoing chemotherapy for the treatment of breast 
cancer and subsequent psychological, emotional, and physical changes. This study 
attempted to draw a distinction between the experience of breast cancer as a whole and 
the process of undergoing chemotherapy. These elements were explored through 
interviews with breast cancer survivors who had undergone chemotherapy. This chapter 
presents the findings in the following order: 1) key findings, 2) implications, 3) 
limitations, and 4) conclusion. 
Key Findings 
In the findings regarding side effects, the vast majority of the women reported 
side effects that were in accordance with the literature. These included fatigue (Servaes, 
Verhagen, and Bleijenberg, 2002), nausea (Molassiotis, 2000), hair loss (Buick, Petrie, 
Booth, Probert, Benjamin, and Harvey, 2000), sleep disturbance (Buick et al., 2000), 
neuropathy, vomiting (Molassiotis, 2000), and cognitive changes (Stewart, Bielajew, 
Collins, Parkinson, and Tomiak, 2006), among others. Side effects that were not 
mentioned in the literature include a blood clot, visual spots, and exacerbation of Super 
Ventricle Tachycardia. It cannot be said that these side effects were caused solely by the 
chemotherapy and not influenced in some way by existing factors. However, all of these 
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side effects had further implications regarding the emotional, physical, and psychological 
well-being of all of the women. 
The findings regarding emotional changes, coping, and support networks were 
supported by the literature in that the women with strong support networks and active 
coping skills felt that they handled the experience well emotionally (Pieterse, van 
Dooren, Seynaeve, Bartels, Rijnsburger, de Koning, Klijn, van Elderen, Tibben, & 
Duivenvoorden, 2007). What was not mentioned in any of the literature was the general 
agreement among the women that they had gained something positive in their lives after 
having gone through chemotherapy. For some (n=7) it was the recognition and greater 
appreciation of their relationships, some (n=7) felt they had re-evaluated their life’s 
priorities, and others (n=5) even felt that they liked themselves better. These findings 
imply more than just negative or neutral changes that take place during the process of 
undergoing chemotherapy. 
The findings about physical and mental changes were also in accordance with the 
literature (Stewart et al., 2006), with several women (n=5) experiencing ‘chemo brain’ as 
a negative occurrence and most (n=9) stating that they had suffered from physical fatigue. 
These effects were closely linked with emotional changes such as depression, depressive 
symptoms like crying, and irritation for eight of the women. One woman reported going 
on anti-depressants during her chemotherapy due to her difficulty in dealing with the 
physical side effects and how that was causing her great emotional distress. Two of the 
women felt that their inability to exercise at their previous levels due to fatigue caused 
them great sadness and frustration. 
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Sense of self was affected for all but four of the women (n=7) in at least a 
minimal way. What was interesting to note was that seven of the women reported liking 
themselves better, while three of these same women also reported negative consequences 
to their self-image. For one this included difficulties that had subsequently arisen in her 
romantic relationship due to her becoming more assertive. This created a dilemma for her 
in determining her ongoing status with this partner, to whom she was not married. 
Previous literature does address improvement in emotional well-being (Hurria, Rosen, 
Hudis, Zuckerman, Panageas, Lachs, Witmer, van Gorp, Fornier, D’Andrea, Moasser, 
Dang, Van Poznak, Hurria, and Holland, 2006), but does not address the issue of overall 
positive life changes experienced by women who have undergone chemotherapy. 
Relationships were affected for eight of the women, with three noting negative 
changes. Many of these changes were linked by the women with changes in self and 
emotion. Several of the women stated that going through a process as harrowing and 
difficult as chemotherapy helped them to realize who their true friends were, the people 
they felt would stay by them through thick and thin. For some, the identity of these 
people was a surprise. All of the married women reported tremendous support from their 
husbands, while two of the single women struggled in their relationships with their 
boyfriends/fiancés. One of the women in particular, who felt her relationship with her 
boyfriend had been negatively affected, felt that it was related to the fact that he was as 
committed to her as a husband would have been. She remarked on the fact that he was 
free to leave at any point, as one woman’s fiancé did, which led her to have many 
ambivalent feelings about having him in her life and led to him being inconsistent in his 
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support of her. The woman whose fiancé left her after bringing her home from surgery 
simply remarked that, “it could have been worse. We could have been married.” 
Spirituality remained fairly constant in most of the women, with only one 
participant self-identifying as atheist. Two of the women felt it had increased their levels 
of spirituality as it helped them to cope with the treatment. Women who maintained high 
levels of spirituality throughout the process attributed much of their progress to God, in 
accordance with the literature and felt they coped well (Tartaro, Roberts, Nosarti, 
Crayford, Luecken, and David, 2005). 
Two of the women felt that their worldview was unaffected by the process and 
maintained their previous perspectives. For the other nine women, responses ranged from 
worrying less to worrying more to changing for a time and then going back to previously 
held beliefs post-treatment. This latter example indicates a shift in worldview used as a 
means to cope and process and then a move away from these beliefs in an effort to 
distance herself from her ‘sick’ identity. Interestingly, this was the one woman who 
identified as having no spiritual or religious beliefs and described herself as having a 
“tremendous ego,” perhaps thereby explaining her need to return to her more ‘normal’ 
state of being. 
There were many concerns expressed through the three stages of before, during, 
and after treatment. What is interesting to note is that none of the women at any time 
expressed a fear or concern with death. Rather, main focuses were on how to keep going, 
concerns with whether the treatment was doing what it ought to, and loved ones. While 
recurrence was a main concern for many (n=8) of the women, it was discussed more in 
terms of future treatment implications than in terms of possible fatality. 
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The findings around causes for these changes and effects indicate that the 
diagnosis of cancer and the treatment of chemotherapy are quite wrapped up in one 
another. The experience was described as one woman as “being on a continuum” and 
described the diagnosis as having so much meaning, partly because of its implication of 
chemotherapy, that it was impossible to distinguish the two from each other. Five of the 
women felt it was not possible to distinguish one from the other, two felt that the 
chemotherapy was the cause of their changes, and four felt that the diagnosis alone had 
the most impact on them. 
Implications 
The implications of these finding for the field of social work include several 
different factors. The purpose of this study was to raise awareness between the possible 
links between a life-threatening treatment for a life-threatening disease and possible 
emotional and psychological side effects that should be addressed by the mental health 
community. This study has shown that undergoing chemotherapy for the treatment of 
breast cancer does, in fact, have at least a minimal effect on the emotional well-being of 
survivors. Mental health professionals should be prepared to identify and discuss 
chemotherapy-related issues independently of the greater cancer experience. 
Another implication from this study is the tremendous positive response that 
many of the participants reported having had. Further research on this angle of the 
process would be interesting in assessing how life-threatening situations can profoundly 
affect people in life re-evaluating ways. Consistency of responses and reactions from this 
subset of women indicate that this is an area that may have far-reaching implications. 
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Differences between married versus non-married women as related to support 
networks and changes in self-identity is another area that bears the need for more 
research as there are implications here about how relationship status can have profound 
meaning and consequences.  Is there a difference in level of support when there is a legal 
commitment to another? This theory would be supported by the example of the woman 
whose fiancé left her right before the beginning of treatment while none of the husbands 
did the same.  Is this commitment culturally reinforced, and if so, how? This also has 
implications for how single women may have been treated differently by their medical 
team than married women. What alternative support systems do single women have, and 
to what extent do they feel they can reliably count on these networks? 
Another common sentiment during the course of the interviews was women 
feeling like their doctors had not provided them with enough information about their 
course of treatment. Perhaps a need for more information about side effects, emotional 
and psychological impacts, and resources for coping need to be more openly shared by 
doctors with their patients. One woman suggested that having a person on her treating 
team who’s sole purpose was to help her understand the medical jargon and the side 
effects would have been extremely helpful. A study around how much information 
provided to patients is helpful, and how much is too much, could be a very useful tool for 
the cancer community. Admittedly, there is a fine line between knowing too little and too 
much. One woman reported that she immediately found that she had to stop looking at 
the Internet as it was overwhelming her with information. Still, a balance between helpful 
knowledge around what is happening, and a certain amount of ignorance may prove to be 
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key in helping women manage their symptoms and experiences and maintain a sense of 
control. 
Limitations 
One of the main limitations of this study is that it was done on a subset of greatly 
similar women. All identified as Caucasian, all but one as spiritual or religious, and all 
with an adequate support network. It was also difficult to ascertain causes for effects and 
changes experienced by the women by having them focus solely on their memories and 
retrospectively. Possibly doing a study in which women are interviewed both before and 
after chemotherapy could yield more conclusiveness in the distinction between the cancer 
experience as a whole, and the chemotherapy effects. 
Another limitation is that all of the women in relationships were with men. There 
was no consideration in this study for same-sex couples and the implications of a partner 
undergoing chemotherapy. All women in this sample were also self-selecting in their 
decision to participate. Since they were recruited via word-of-mouth there is an implied 
web of relatedness, both among themselves, and with the interviewer. 
Conclusion 
The current study provides useful data on changes that occur during and following 
the use of chemotherapy to treat breast cancer. While many themes did emerge, each 
woman’s narrative and story was uniquely her own. Each had a very private experience 
of going through treatment and felt that she had gained something within herself or her 
life that led her to want to participate in this study. No one experience, relayed during the 
course of a single interview, can express the tremendous courage with which each of 
these women, and all those who undergo the daunting rigors of such a treatment, faced 
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their mortality. As one woman put it, and as each expressed in her own way, “it’s life 
changing.” 
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Appendix A 
Human Subjects Review Application and Approval Letter 
Investigator Name:  Amy Willson 
 
Project Title: The Breast Cancer Survivor’s Experience of Undergoing Chemotherapy 
 
Project Purpose and Design 
Chemotherapy is a concept that strikes a chord inside many people, conjuring 
images of nausea, hair loss, and pain.  It is synonymous with cancer.  The impact of 
undergoing treatment for a life-threatening diagnosis like cancer can have both seen and 
unseen impacts on the person, their families, and their loved ones.  The effects can 
reverberate through a person’s life, affecting not only their health status, but also their 
relationships, careers, sense of self, worldview, and spirituality.  When chemotherapy is 
chosen as a method of treatment this impacts the person’s experience of the illness as it 
can cause a myriad of side effects that range from mild to life threatening, in and of 
themselves.  These can lead to an array of responses that range from mild discomfort to 
symptoms of trauma (Stewart, Bielajew, Collins, Parkinson, and Tomiak, 2006, Mehnert 
and Koch, 2007, and Rabin, Leventhal, and Goodin, 2004).  For many, chemotherapy 
changes the landscapes of their lives and is often regarded as being worse than the cancer 
(Docherty, Sandelowski, and Preisser, 2006).  The DSM-IV-TR includes “being 
diagnosed with a life-threatening illness” as a traumatic event that can lead to the 
symptoms and diagnosis of Posttraumatic Stress Disorder (PTSD) (DSM-IV-TR, 2000, p. 
462).  To the best of my knowledge, this is the first study that proposes to closely 
examine the specific stressors that can arise from chemotherapy as it is considered 
independently from cancer.  Previous research has found that individuals undergoing 
 78 
chemotherapy experience changes in quality of life (e.g. Zebrack, Yi, Petersen, and Ganz, 
2007, Hurria, A., Rosen, Hudis, Zuckerman, Panageas, Lachs, Witmer, van Gorp, 
Fornier, D’Andrea, Moasser, Dang, Van Poznak, Hurria, and Holland, 2006, and Carver, 
Smith, Petronis, and Antoni, 2006), anticipatory nausea (e.g. Montgomery, Bovbjerg, 
2003, and Montgomery,Bovbjerg, 2001), cognitive impairment (e.g. Falleti, Sanfilippo, 
Maruff, Weih, and Phillips, 2005, and Bender, Sereika, Berga, Vogel, Brufsky, Paraska, 
and Ryan, 2006), depression and anxiety (e.g. Reddick, Nanda, Campbell, Ryman, and 
Gaston-Johansson, 2005, and Deshields, Tibbs, Fan, and Taylor, 2006), and fatigue (e.g. 
Jacobsen, Hann, Azzarello, Horton, Balducci, and Lyman, 1999, and Mills, Parker, 
Dimsdale, Sadler, and Ancoli-Israel, 2005).  None of these studies, however, have looked 
at how these chemotherapy side effects have affected the realms of spirituality, sense of 
self, world view, and sexuality, as this study plans to do. 
What is it like when the treatment for the illness is what many consider to be the 
worst part?  What about effects that aren’t considered to be traumatic, but still impact 
one’s life?  This study will look more closely at the experiences of women who have 
undergone chemotherapy for the treatment of breast cancer and will consider the full 
range of experiences to better understand the effects it has on people’s lives.  
Specifically, the purpose of this study is to lay the groundwork for the understanding of 
the impact of chemotherapy on breast cancer survivors. However, the implications of the 
findings of this study can be broadened and generalized to other cancers that have a 
chemotherapy protocol as well.  These findings can be translated into ways to provide 
more emotional, physical, spiritual, and mental support for patients undergoing 
chemotherapy and allow for a better understanding of what happens when someone 
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undergoes a life-threatening treatment.  While the chemotherapy experience may not be 
explicitly traumatic, it is possible that it is on a spectrum that includes its own set of 
psychologically distressing symptoms that need to be addressed in the field of mental 
health. 
Through one-to-one interviews with women who have been treated for breast 
cancer, I plan to focus in-depth on what the experience of chemotherapy was like for 
these women and how it changed their lives, for good, bad, or not at all.  This kind of 
information can lead to a better understanding of what is needed by cancer patients 
before, during, and after chemotherapy.  Are their mental health needs being met?  Are 
their relationships being strained?  Has it raised questions regarding their faith?  Do they 
regret the decision?  All of these are important factors to consider when treating a person 
as a whole and should not be overlooked by the medical and mental health communities. 
According to Boyatzis, the purpose of analyses of data in social work studies is to 
summarize and describe the meaning and content of the answers (Anastas, 1999).  The 
interviews will start with an explanation from me about the purpose of the study and an 
invitation to the participant to describe in as much detail as they feel comfortable, what 
chemotherapy was like for them, including the context of their life when it began.  The 
purpose of conducting the interviews in such an open-ended manner is to allow the 
participants to connect with their material in their own way and to describe the situation 
in a totally subjective manner. 
It is possible that questions designed to illicit a deeper response may be used in 
some instances, such as “What did you think about while you were in the chair getting 
chemo?” and “What was it like for your family and loved ones?”  Interviews will be 
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audio recorded, and I will also take notes during them noting affect and anything else of 
significance.  These field notes will be correlated with each interview during the 
transcription process and similarities and discrepancies will be noted in the analysis.  I 
will analyze the data using the grounded theory method that is “explicitly designed for 
‘the discovery of theory from data systematically obtained and analyzed in social 
research’” (Anastas, 1999, p.61). 
The research from this study will be used in my MSW thesis for the Smith 
College School for Social Work where it will be presented to my peers and colleagues in 
partial fulfillment of my graduation requirements.  This research will be used for possible 
presentation and publication and a copy of it will remain in the Smith library. 
The Characteristics of the Participants 
Participants in this study must be women 18 and older, fluent in English, who 
have undergone chemotherapy specifically for the treatment of breast cancer.  They must 
be between six months and five years from the end of chemotherapy.  There are no 
specific exclusionary characteristics if the women fall into these categories.  I would like 
to have a broad range of age, race, religion, socioeconomic status, and marital status.  A 
sample size of 12 to 15 women is ideal. 
The Recruitment Process 
The recruitment will take place in Denver, Colorado and will take place through 
word of mouth initially beginning through connections and associates of my mother, 
herself a breast cancer survivor.  Through my mother and her friends and colleagues 
eligible participants will be identified and given my contact information with which to 
follow-up.  For participants who may be known to me, they will receive a brief 
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description of the study, its requirements, and my contact information.  If they chose to 
contact me a phone interview will follow and at no time will I be informed of their names 
or addresses.  For others, they will also receive my contact information and I will also 
receive theirs through our mutual contact.  These interviews may happen over the phone 
or in person, at the participant’s discretion. This open method of recruitment will allow 
for the most diverse sample to be obtained in that a broad range of possible participants 
will be notified through my mother and her contacts. 
The Nature of Participation 
Interviews will be expected to last no more than an hour.  Participants need only 
show up and be willing to have the interview tape recorded.  Participants will have the 
option of deciding where they would like to conduct the face-to-face interviews.  
Interviews will be conducted in a private room at a local library, which I will obtain 
permission to use ahead of time.  If a phone interview is indicated, if I know the 
participant or they are more comfortable with this format, this will be arranged in lieu of 
a face-to-face interview. Phone interviews will be recorded using a recording device 
designed for this purpose.  Demographic data, including age, age at diagnosis, stage of 
cancer, and family history of cancer, race, religion, occupation, and marital status will be 
collected to ensure a broad range of experiences and ensure diversity.  A form will be 
provided to subjects, either through mail or email, to fill out prior to the interview, as 
well as the Informed Consent form.  For phone interviews these forms will not be 
required, instead a copy of the Informed Consent will be provided to them prior to the 
interview by our mutual contact.  This will also include a stamped envelope addressed to 
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myself.  Verbal consent also will be obtained over the phone and demographic data will 
be collected verbally.  All interviews will be transcribed by myself. 
Risks of Participation 
The primary risk of participating in this study is that interviewees may experience 
some degree of emotional stress or trigger.  Discussing an experience like chemotherapy 
can be upsetting and make the participant feel vulnerable.  These risks will be discussed 
openly and participants reassured that they may stop the interview at any time.  The 
women will be provided with a list of local mental health professionals, clinics, and 
hotlines in the event that they feel they need to talk to someone following the interview.  
They will also be reassured that all information gathered will be held in confidence by 
myself.  My thesis advisor will only have access to their information once all identifying 
information has been removed.  Names will not be used in the study and identifying 
characteristics will be minimal. 
Benefits of Participation 
A primary benefit of participating in this study will be the participant’s 
knowledge that her experience and sharing of it can potentially lead to a better 
understanding and system of care for others who have to undergo similarly invasive and 
traumatizing protocols.  Additionally, the chance to process the experience and share it 
with another may provide new understanding about it for the participant and may help her 
to think of it in previously unconsidered terms. 
Informed Consent Procedures 
Informed Consent forms will be mailed to participants at least a week before the 
interview is to take place as a way to give participants a chance to read it and think of any 
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questions or concerns ahead of time.  This will include a stamped return envelope if they 
chose to mail it back to me rather than bring it to the interview.  I will bring extra copies 
as well in the event that a participant forgets to bring hers.  I will collect a signed copy 
from each participant and also provide a blank copy for each subject to retain for her own 
records.  In the case of a phone interview, the Informed Consent form need to have been 
returned to me prior to the interview, by mail.  Two copies of the Informed Consent will 
be provided to them prior to the interview by our mutual contact, one to sign and return, 
and one to keep for their records.  I will also include a stamped envelope addressed to 
myself in which to return the consent form. 
Precautions Taken to Safeguard Confidentiality and Identifiable Information 
Confidentiality will be protected in this study by not including any personally 
identifying information in the interviews beyond previously mentioned demographic 
data, and keeping responses in a locked box.  I will blind all data by referring to subjects 
by a randomly assigned number instead of using their name to track participation and 
data collection. Data used in quotations and vignettes will also be disguised.  Any 
questions may be skipped and not answered and participants may drop out of the study at 
any time during the data collection process or after, up until April 30, 2008.   All 
information will be shared will my thesis advisor only after all identifying characteristics 
have been removed or disguised.  All data collected, including notes, transcripts, tapes, 
etc., will be kept for 3 years in a secure location, as per federal guidelines.  If materials 
are needed longer they will continue to be stored securely and will be securely destroyed 
when no longer needed.  I will make available the names and numbers of organizations 
offering support to cancer survivors as well as the names and numbers of practicing 
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clinicians in their areas.  All areas of concern are addressed in the Informed Consent and 
any additional questions or concerns that may arise may be addressed to me via phone or 
email at any time. 
Investigator’s Signature:___Amy Willson______________Date:__1/26/08_______ 
Advisor’s Signature:_______________________________Date:______________ 
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February 27, 2008 
 
 
Amy Willson 
 
Dear Amy, 
 
Your second set of revisions has been reviewed and all is now in order.  We are therefore 
glad to give final approval to your study. 
 
Please note the following requirements: 
 
Consent Forms:  All subjects should be given a copy of the consent form. 
 
Maintaining Data:  You must retain signed consent documents for at least three (3) 
years past completion of the research activity. 
 
In addition, these requirements may also be applicable: 
 
Amendments:  If you wish to change any aspect of the study (such as design, 
procedures, consent forms or subject population), please submit these changes to the 
Committee. 
 
Renewal:  You are required to apply for renewal of approval every year for as long as the 
study is active. 
 
Completion:  You are required to notify the Chair of the Human Subjects Review 
Committee when your study is completed (data collection finished).  This requirement is 
met by completion of the thesis project during the Third Summer. 
 
Good luck with your project. 
 
Sincerely, 
 
 
 
Ann Hartman, D.S.W. 
Chair, Human Subjects Review Committee 
 
CC: Jill Clemence, Research Advisor 
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Appendix B 
Informed Consent Form 
Dear Participant, 
 
My name is Amy Willson. I am conducting a research study of breast cancer 
survivors to learn more about the experience of chemotherapy and its effect on identity, 
self, worldview, and other areas of change. The purpose of this is to learn more about 
possible additional supports that could be put into place for such a population.  The study 
is being conducted for my thesis in the Master of Social Work program at the Smith 
College School for Social Work and may be presented and used for publication. 
 
I am interested in exploring the experiences and life changes, if any, experienced 
by women who have been treated with a chemotherapy protocol for breast cancer. You 
are being asked to participate in this study if (a) you are over the age of eighteen (18), (b) 
you have had chemotherapy for breast cancer and (c) you are between six (6) months and 
five (5) years past treatment. As a participant in this study you will asked to participate in 
a face-to-face interview, or a phone interview. Face-to-face interviews will be conducted 
in a private room of a local library, to be arranged ahead of time by me, to ensure 
confidentiality.  Questions will focus on your experience while undergoing 
chemotherapy. The interview will take between 45 to 60 minutes. Interviews will be 
audio recorded and tapes will be transcribed and coded numerically by myself to ensure 
your confidentiality.  Tapes will be destroyed after three (3) years, along with all other 
study material.  All interviews will be transcribed by myself.  You will also be asked to 
fill out a brief demographic questionnaire at the beginning of the interview to collect 
background data for the study. 
 
The potential risks of participating in this study are the possibility that you might 
feel strong or uncomfortable emotions while talking about your experiences. In case you 
feel the need for additional support after participating in this study, you will be given a 
list of resources for mental health services in your area. 
 
Your participation in this study is completely voluntary. You will receive no 
financial benefit for your participation in this study.  You may benefit from knowing that 
you have contributed to the knowledge of mental health treatment of cancer patients 
undergoing chemotherapy. It is my hope that this study will help social workers have a 
better understanding of how to work more effectively with those diagnosed with breast 
cancer. You may also benefit from being able to tell your story and having your 
perspective heard. 
 
Strict confidentiality will be maintained, as consistent with Federal regulations 
and the mandates of the social work profession. Coding the information and storing the 
data in a locked file for a minimum of 3 years will protect confidentiality. Should I need 
the materials beyond the 3 year period they will continue to be kept in a secure location 
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and will be destroyed when no longer needed.  Your identity will be protected, as names 
will be changed in the analysis of the data. Your name will never be associated with the 
information you provide in the questionnaire or the interview, but your demographic 
information will be used. The data may be used in other educational activities as well as 
in the preparation for my Master’s thesis and may been seen by my thesis advisor once 
identifying information has been removed.  When my thesis is presented the data will be 
presented as a whole and when brief illustrative quotes or vignettes are used they will be 
carefully disguised.  Any concerns regarding confidentiality may be further discussed 
with me before the interview commences. 
 
This study is completely voluntary. You are free to refuse to answer specific 
questions and to withdraw from the interview at any time. If you decide to withdraw, all 
data describing you will be immediately destroyed.  If you decide to withdraw wholly 
from the study you may do so by notifying me by April 30, 2008.  You may reach me at 
any time via phone or email at the number below, to discuss concerns or questions and 
you may contact the Smith College School for Social Work Human Subjects Review 
Committee at 413-585-7974. 
 
YOUR SIGNATURE INDICATES THAT YOU HAVE READ AND 
UNDERSTAND THE ABOVE INFORMATION AND THAT YOU HAVE HAD 
THE OPPORTUNITY TO ASK QUESTIONS ABOUT THE STUDY, YOUR 
PARTICIPATION, AND YOUR RIGHTS AND THAT YOU AGREE TO 
PARTICIPATE IN THE STUDY. 
 
SIGNATURE OF PARTICIPANT             SIGNATURE OF RESEARCHER 
 
 
 
____________________________   ____________________________ 
DATE       DATE 
 
 
If you have any questions or wish to withdraw your consent, please contact: Amy 
Willson.  Please keep a copy of this consent for your own records. 
 
 
 
Sincerely, 
 
 
Amy Willson 
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Appendix C 
Demographic Information Form 
 
Birthdate and age: 
Date diagnosed with breast cancer: 
Stage of cancer with which you were diagnosed: 
Family history of cancer: 
Race/ethnicity: 
Occupation: 
Marital status: 
Religious affiliation: 
 
(for researcher to assign) Number: 
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Appendix D 
Interview Guide 
1) What was going on in your life when you were receiving chemotherapy?  What 
was the context?  This may include other treatments you may have previously 
received. 
2) When were you diagnosed?  What factors contributed to your decision to undergo 
chemotherapy?  Family?  Family history?  Friends?  What did your doctor tell you 
about it and how did they present it to you? 
3) How did you explain the decision to yourself?  Your family? 
4) Who supported you during the process?  Sat with you?  Drove you?   
5) What was your biggest concern before the protocol began?  During? After? 
6) What did you think about while you were receiving the chemotherapy?  (For 
those who received it via I.V.)  Did you visualize what was happening in your 
body?  If so, how? 
7) What side effects, if any, did you experience?  How well did you tolerate it? What 
was that like for you emotionally?  Physically? 
8) Did you decide to continue/not continue with chemotherapy?  Why or why not? 
9) What changed for you during the treatment emotionally?  Mentally?  Physically?  
Were there any positive changes in your life?  Negative changes?  What’s 
different now?  What’s the same? 
10) Did it affect your worldview?  Spirituality?  Relationships?  Sense of self? 
11) What would it have been like if you hadn’t decided to get chemotherapy? 
 
 90 
12) Do you feel your reaction was due to the chemotherapy or to the diagnosis of 
cancer itself, or both? 
      13) Is there anything you would like to add?  Any questions for me? 
 
 
 
 
 
 
 
